{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:51Z","timestamp":1792788291532,"version":"4.5.0"},"reference-count":284,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["32300959"],"award-info":[{"award-number":["32300959"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Guangzhou Scientific Research Grant","award":["SL2024A04J00578"],"award-info":[{"award-number":["SL2024A04J00578"]}]},{"name":"SCNU Young Faculty Development Program","award":["22KJ04"],"award-info":[{"award-number":["22KJ04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-03083-9","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:53:31Z","timestamp":1784098411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TREM2 in neurodegenerative diseases and acute neurological injuries: mechanisms to targeted therapies"],"prefix":"10.1186","volume":"24","author":[{"given":"Haixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiming","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-7054","authenticated-orcid":false,"given":"Luodan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"3083_CR1","first-page":"2937","volume":"16","author":"S Wang","year":"2024","unstructured":"Wang S, Jiang Y, Yang A, Meng F, Zhang J. The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need. Aging Dis. 2024;16:2937\u201352.","journal-title":"Aging Dis"},{"key":"3083_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"key":"3083_CR3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.14336\/AD.2023.0628","volume":"15","author":"Q Huang","year":"2024","unstructured":"Huang Q, Wang Y, Chen S, Liang F. Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation. Aging Dis. 2024;15:1155\u201375.","journal-title":"Aging Dis"},{"key":"3083_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y, Cairns NJ, Kambal A, et al. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease. Cell. 2017;170:649\u2013e663613.","journal-title":"Cell"},{"key":"3083_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/1521-4141(200201)32:1<59::AID-IMMU59>3.0.CO;2-U","volume":"32","author":"DH Chung","year":"2002","unstructured":"Chung DH, Seaman WE, Daws MR. Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17. Eur J Immunol. 2002;32:59\u201366.","journal-title":"Eur J Immunol"},{"key":"3083_CR6","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/febs.17353","volume":"292","author":"F Vasilopoulou","year":"2025","unstructured":"Vasilopoulou F, Piers TM, Wei J, Hardy J, Pocock JM. Amelioration of signaling deficits underlying metabolic shortfall in TREM2(R47H) human iPSC-derived microglia. Febs j. 2025;292:1743\u201362.","journal-title":"Febs j"},{"key":"3083_CR7","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","volume":"61","author":"P Huang","year":"2024","unstructured":"Huang P, Zhang Z, Zhang P, Feng J, Xie J, Zheng Y, Liang X, Zhu B, Chen Z, Feng S, et al. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson\u2019s Disease Mice and LPS-Induced BV2 Cells. Mol Neurobiol. 2024;61:2590\u2013605.","journal-title":"Mol Neurobiol"},{"key":"3083_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","volume":"23","author":"FL Yeh","year":"2017","unstructured":"Yeh FL, Hansen DV, Sheng M. TREM2, Microglia, and Neurodegenerative Diseases. Trends Mol Med. 2017;23:512\u201333.","journal-title":"Trends Mol Med"},{"key":"3083_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","volume":"17","author":"J Yang","year":"2020","unstructured":"Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z. TREM2 ectodomain and its soluble form in Alzheimer\u2019s disease. J Neuroinflammation. 2020;17:204.","journal-title":"J Neuroinflammation"},{"key":"3083_CR10","doi-asserted-by":"publisher","first-page":"115962","DOI":"10.1016\/j.biopha.2023.115962","volume":"170","author":"W Wei","year":"2024","unstructured":"Wei W, Zhang L, Xin W, Pan Y, Tatenhorst L, Hao Z, Gerner ST, Huber S, Juenemann M, Butz M, et al. TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury. Biomed Pharmacother. 2024;170:115962.","journal-title":"Biomed Pharmacother"},{"key":"3083_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3233\/JAD-215602","volume":"87","author":"BC Shaw","year":"2022","unstructured":"Shaw BC, Snider HC, Turner AK, Zajac DJ, Simpson JF, Estus S. An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain. J Alzheimers Dis. 2022;87:1647\u201357.","journal-title":"J Alzheimers Dis"},{"key":"3083_CR12","doi-asserted-by":"publisher","first-page":"6937","DOI":"10.1038\/s41598-018-25204-2","volume":"8","author":"M Yanaizu","year":"2018","unstructured":"Yanaizu M, Sakai K, Tosaki Y, Kino Y, Satoh JI. Small nuclear RNA-mediated modulation of splicing reveals a therapeutic strategy for a TREM2 mutation and its post-transcriptional regulation. Sci Rep. 2018;8:6937.","journal-title":"Sci Rep"},{"key":"3083_CR13","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","volume":"164","author":"A Bouchon","year":"2000","unstructured":"Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991\u20135.","journal-title":"J Immunol"},{"key":"3083_CR14","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, Norton JB, Hsu S, Harari O, Cai Y, et al. Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet. 2014;23:5838\u201346.","journal-title":"Hum Mol Genet"},{"key":"3083_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2009.01.009","volume":"21","author":"JW Ford","year":"2009","unstructured":"Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009;21:38\u201346.","journal-title":"Curr Opin Immunol"},{"key":"3083_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/JLB.2HI0720-463RR","volume":"110","author":"K Kiianitsa","year":"2021","unstructured":"Kiianitsa K, Kurtz I, Beeman N, Matsushita M, Chien WM, Raskind WH, Korvatska O. Novel TREM2 splicing isoform that lacks the V-set immunoglobulin domain is abundant in the human brain. J Leukoc Biol. 2021;110:829\u201337.","journal-title":"J Leukoc Biol"},{"key":"3083_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12974-018-1148-y","volume":"15","author":"JT Li","year":"2018","unstructured":"Li JT, Zhang Y. TREM2 regulates innate immunity in Alzheimer\u2019s disease. J Neuroinflammation. 2018;15:107.","journal-title":"J Neuroinflammation"},{"key":"3083_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-019-0319-3","volume":"14","author":"JL Del-Aguila","year":"2019","unstructured":"Del-Aguila JL, Benitez BA, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, Farias FHG, Fern\u00e1ndez MV, Ibanez L, Jiang S, et al. TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers. Mol Neurodegener. 2019;14:18.","journal-title":"Mol Neurodegener"},{"key":"3083_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/immu.200310033","volume":"33","author":"RJ Allcock","year":"2003","unstructured":"Allcock RJ, Barrow AD, Forbes S, Beck S, Trowsdale J. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol. 2003;33:567\u201377.","journal-title":"Eur J Immunol"},{"key":"3083_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2017.09.034","volume":"660","author":"D Feuerbach","year":"2017","unstructured":"Feuerbach D, Schindler P, Barske C, Joller S, Beng-Louka E, Worringer KA, Kommineni S, Kaykas A, Ho DJ, Ye C, et al. ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. Neurosci Lett. 2017;660:109\u201314.","journal-title":"Neurosci Lett"},{"key":"3083_CR21","doi-asserted-by":"publisher","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J. Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage. J Biol Chem. 2013;288:33027\u201336.","journal-title":"J Biol Chem"},{"key":"3083_CR22","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.14283\/jpad.2024.164","volume":"11","author":"M Lin","year":"2024","unstructured":"Lin M, Yu JX, Zhang WX, Lao FX, Huang HC. Roles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer\u2019s Disease. J Prev Alzheimers Dis. 2024;11:1682\u201395.","journal-title":"J Prev Alzheimers Dis"},{"key":"3083_CR23","doi-asserted-by":"publisher","first-page":"ra38","DOI":"10.1126\/scisignal.2000500","volume":"3","author":"Q Peng","year":"2010","unstructured":"Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 2010;3:ra38.","journal-title":"Sci Signal"},{"key":"3083_CR24","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.15252\/emmm.201707672","volume":"9","author":"K Schlepckow","year":"2017","unstructured":"Schlepckow K, Kleinberger G, Fukumori A, Feederle R, Lichtenthaler SF, Steiner H, Haass C. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO Mol Med. 2017;9:1356\u201365.","journal-title":"EMBO Mol Med"},{"key":"3083_CR25","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1096\/fj.201902183R","volume":"34","author":"DK Berner","year":"2020","unstructured":"Berner DK, Wessolowski L, Armbrust F, Schneppenheim J, Schlepckow K, Koudelka T, Scharfenberg F, Lucius R, Tholey A, Kleinberger G, et al. Meprin \u03b2 cleaves TREM2 and controls its phagocytic activity on macrophages. Faseb j. 2020;34:6675\u201387.","journal-title":"Faseb j"},{"key":"3083_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-016-0137-9","volume":"11","author":"L Ma","year":"2016","unstructured":"Ma L, Allen M, Sakae N, Ertekin-Taner N, Graff-Radford NR, Dickson DW, Younkin SG, Sevlever D. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer\u2019s disease brains. Mol Neurodegener. 2016;11:72.","journal-title":"Mol Neurodegener"},{"key":"3083_CR27","doi-asserted-by":"publisher","first-page":"243ra286","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Su\u00e1rez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6:243ra286.","journal-title":"Sci Transl Med"},{"key":"3083_CR28","doi-asserted-by":"publisher","unstructured":"Lessard CB, Malnik SL, Zhou Y, Ladd TB, Cruz PE, Ran Y, Mahan TE, Chakrabaty P, Holtzman DM, Ulrich JD, et al. High-affinity interactions and signal transduction between A\u03b2 oligomers and TREM2. EMBO Mol Med. 2018;10. https:\/\/doi.org\/10.15252\/emmm.201809027.","DOI":"10.15252\/emmm.201809027"},{"key":"3083_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12264-022-00944-4","volume":"39","author":"WA Mills 3rd","year":"2023","unstructured":"Mills WA 3rd, Eyo UB. TREMble Before TREM2: The Mighty Microglial Receptor Conferring Neuroprotective Properties in TDP-43 Mediated Neurodegeneration. Neurosci Bull. 2023;39:163\u20136.","journal-title":"Neurosci Bull"},{"key":"3083_CR30","doi-asserted-by":"publisher","first-page":"e2400064","DOI":"10.1002\/advs.202400064","volume":"11","author":"JC Park","year":"2024","unstructured":"Park JC, Han JW, Lee W, Kim J, Lee SE, Lee D, Choi H, Han J, Kang YJ, Diep YN, et al. Microglia Gravitate toward Amyloid Plaques Surrounded by Externalized Phosphatidylserine via TREM2. Adv Sci (Weinh). 2024;11:e2400064.","journal-title":"Adv Sci (Weinh)"},{"key":"3083_CR31","doi-asserted-by":"publisher","first-page":"7508","DOI":"10.1038\/s41598-019-43535-6","volume":"9","author":"K Shirotani","year":"2019","unstructured":"Shirotani K, Hori Y, Yoshizaki R, Higuchi E, Colonna M, Saito T, Hashimoto S, Saito T, Saido TC, Iwata N. Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells. Sci Rep. 2019;9:7508.","journal-title":"Sci Rep"},{"key":"3083_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4049\/jimmunol.171.2.594","volume":"171","author":"MR Daws","year":"2003","unstructured":"Daws MR, Sullam PM, Niemi EC, Chen TT, Tchao NK, Seaman WE. Pattern recognition by TREM-2: binding of anionic ligands. J Immunol. 2003;171:594\u20139.","journal-title":"J Immunol"},{"key":"3083_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-024-00795-9","volume":"20","author":"JA Greven","year":"2025","unstructured":"Greven JA, Wydra JR, Greer RA, Zhi C, Price DA, Svoboda JD, Camitta CLM, Washington M, Leung DW, Song Y, et al. Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple Alzheimer\u2019s disease ligands. Mol Neurodegener. 2025;20:3.","journal-title":"Mol Neurodegener"},{"key":"3083_CR34","doi-asserted-by":"publisher","first-page":"12634","DOI":"10.1074\/jbc.RA118.002352","volume":"293","author":"A Sudom","year":"2018","unstructured":"Sudom A, Talreja S, Danao J, Bragg E, Kegel R, Min X, Richardson J, Zhang Z, Sharkov N, Marcora E, et al. Molecular basis for the loss-of-function effects of the Alzheimer\u2019s disease-associated R47H variant of the immune receptor TREM2. J Biol Chem. 2018;293:12634\u201346.","journal-title":"J Biol Chem"},{"key":"3083_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, Sun Y, Zhu B, Pi\u00f1a-Crespo JC, Zhang M, et al. TREM2 Is a Receptor for \u03b2-Amyloid that Mediates Microglial Function. Neuron. 2018;97:1023\u2013e10311027.","journal-title":"Neuron"},{"key":"3083_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","volume":"23","author":"M Colonna","year":"2023","unstructured":"Colonna M. The biology of TREM receptors. Nat Rev Immunol. 2023;23:580\u201394.","journal-title":"Nat Rev Immunol"},{"key":"3083_CR37","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41593-020-0650-6","volume":"23","author":"BJ Andreone","year":"2020","unstructured":"Andreone BJ, Przybyla L, Llapashtica C, Rana A, Davis SS, van Lengerich B, Lin K, Shi J, Mei Y, Astarita G, et al. Alzheimer\u2019s-associated PLC\u03b32 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat Neurosci. 2020;23:927\u201338.","journal-title":"Nat Neurosci"},{"key":"3083_CR38","doi-asserted-by":"publisher","first-page":"967825","DOI":"10.3389\/fnagi.2022.967825","volume":"14","author":"S Liu","year":"2022","unstructured":"Liu S, Cao X, Wu Z, Deng S, Fu H, Wang Y, Liu F. TREM2 improves neurological dysfunction and attenuates neuroinflammation, TLR signaling and neuronal apoptosis in the acute phase of intracerebral hemorrhage. Front Aging Neurosci. 2022;14:967825.","journal-title":"Front Aging Neurosci"},{"key":"3083_CR39","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1523\/JNEUROSCI.2459-16.2017","volume":"37","author":"H Zheng","year":"2017","unstructured":"Zheng H, Jia L, Liu CC, Rong Z, Zhong L, Yang L, Chen XF, Fryer JD, Wang X, Zhang YW, et al. TREM2 Promotes Microglial Survival by Activating Wnt\/\u03b2-Catenin Pathway. J Neurosci. 2017;37:1772\u201384.","journal-title":"J Neurosci"},{"key":"3083_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12974-025-03337-2","volume":"22","author":"L Wang","year":"2025","unstructured":"Wang L, Ouyang D, Li L, Cao Y, Wang Y, Gu N, Zhang Z, Li Z, Tang S, Tang H, et al. TREM2 affects DAM-like cell transformation in the acute phase of TBI in mice by regulating microglial glycolysis. J Neuroinflammation. 2025;22:6.","journal-title":"J Neuroinflammation"},{"key":"3083_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.freeradbiomed.2025.05.417","volume":"237","author":"S Liu","year":"2025","unstructured":"Liu S, Dong Y, Zhang X, Pan X, Wang R, Ma H, Sun N, Cao X. Neuroprotection in spinal cord ischemia-reperfusion injury: Diosmetin\u2019s role via TREM2-mediated microglial pyroptosis. Free Radic Biol Med. 2025;237:369\u201382.","journal-title":"Free Radic Biol Med"},{"key":"3083_CR42","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.4049\/jimmunol.163.9.4651","volume":"163","author":"C Chang","year":"1999","unstructured":"Chang C, Dietrich J, Harpur AG, Lindquist JA, Haude A, Loke YW, King A, Colonna M, Trowsdale J, Wilson MJ. Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J Immunol. 1999;163:4651\u20134.","journal-title":"J Immunol"},{"key":"3083_CR43","doi-asserted-by":"publisher","first-page":"ra72","DOI":"10.1126\/scisignal.2003801","volume":"6","author":"Q Peng","year":"2013","unstructured":"Peng Q, Long CL, Malhotra S, Humphrey MB. A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages. Sci Signal. 2013;6:ra72.","journal-title":"Sci Signal"},{"key":"3083_CR44","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/s41467-023-42505-x","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang L, Yang J, Meng L, Chen J, Zhou L, Wang J, Xiong M, Zhang Z. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer\u2019s disease. Nat Commun. 2023;14:6670.","journal-title":"Nat Commun"},{"key":"3083_CR45","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160:1061\u201371.","journal-title":"Cell"},{"key":"3083_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","volume":"48","author":"F Filipello","year":"2018","unstructured":"Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, Erreni M, Markicevic M, Starvaggi-Cucuzza C, Otero K, et al. The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. Immunity. 2018;48:979\u2013e991978.","journal-title":"Immunity"},{"key":"3083_CR47","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, Lei T, Hou J, Cai Z, Cella M, et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell. 2022;185:4153\u2013e41694119.","journal-title":"Cell"},{"key":"3083_CR48","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O\u2019Loughlin E, Xu Y, Fanek Z, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47:566\u2013e581569.","journal-title":"Immunity"},{"key":"3083_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-022-00552-w","volume":"17","author":"JV Haure-Mirande","year":"2022","unstructured":"Haure-Mirande JV, Audrain M, Ehrlich ME, Gandy S. Microglial TYROBP\/DAP12 in Alzheimer\u2019s disease: Transduction of physiological and pathological signals across TREM2. Mol Neurodegener. 2022;17:55.","journal-title":"Mol Neurodegener"},{"key":"3083_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/alz.12256","volume":"17","author":"M Audrain","year":"2021","unstructured":"Audrain M, Haure-Mirande JV, Mleczko J, Wang M, Griffin JK, St George-Hyslop PH, Fraser P, Zhang B, Gandy S, Ehrlich ME. Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer\u2019s-related mice. Alzheimers Dement. 2021;17:149\u201363.","journal-title":"Alzheimers Dement"},{"key":"3083_CR51","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.immuni.2023.06.016","volume":"56","author":"L Zhong","year":"2023","unstructured":"Zhong L, Sheng X, Wang W, Li Y, Zhuo R, Wang K, Zhang L, Hu DD, Hong Y, Chen L, et al. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration. Immunity. 2023;56:1794\u2013e18081798.","journal-title":"Immunity"},{"key":"3083_CR52","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"3083_CR53","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169:1276\u2013e12901217.","journal-title":"Cell"},{"key":"3083_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med. 2020;26:131\u201342.","journal-title":"Nat Med"},{"key":"3083_CR55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-020-02200-3","volume":"140","author":"AT Nguyen","year":"2020","unstructured":"Nguyen AT, Wang K, Hu G, Wang X, Miao Z, Azevedo JA, Suh E, Van Deerlin VM, Choi D, Roeder K, et al. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer\u2019s disease. Acta Neuropathol. 2020;140:477\u201393.","journal-title":"Acta Neuropathol"},{"key":"3083_CR56","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","volume":"11","author":"A McQuade","year":"2020","unstructured":"McQuade A, Kang YJ, Hasselmann J, Jairaman A, Sotelo A, Coburn M, Shabestari SK, Chadarevian JP, Fote G, Tu CH, et al. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat Commun. 2020;11:5370.","journal-title":"Nat Commun"},{"key":"3083_CR57","doi-asserted-by":"publisher","unstructured":"Chen Y, Colonna M. Microglia in Alzheimer\u2019s disease at single-cell level. Are there common patterns in humans and mice? J Exp Med. 2021;218. https:\/\/doi.org\/10.1084\/jem.20202717.","DOI":"10.1084\/jem.20202717"},{"key":"3083_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22:191\u2013204.","journal-title":"Nat Neurosci"},{"key":"3083_CR59","doi-asserted-by":"publisher","unstructured":"Zhao N, Qiao W, Li F, Ren Y, Zheng J, Martens YA, Wang X, Li L, Liu CC, Chen K, et al. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. J Exp Med. 2022;219. https:\/\/doi.org\/10.1084\/jem.20212479.","DOI":"10.1084\/jem.20212479"},{"key":"3083_CR60","doi-asserted-by":"publisher","first-page":"110883","DOI":"10.1016\/j.celrep.2022.110883","volume":"39","author":"R Dhandapani","year":"2022","unstructured":"Dhandapani R, Neri M, Bernhard M, Brzak I, Schweizer T, Rudin S, Joller S, Berth R, Kernen J, Neuhaus A, et al. Sustained Trem2 stabilization accelerates microglia heterogeneity and A\u03b2 pathology in a mouse model of Alzheimer\u2019s disease. Cell Rep. 2022;39:110883.","journal-title":"Cell Rep"},{"key":"3083_CR61","doi-asserted-by":"publisher","first-page":"e2413451","DOI":"10.1002\/advs.202413451","volume":"12","author":"M Xiong","year":"2025","unstructured":"Xiong M, Xia D, Yu H, Meng L, Zhang X, Chen J, Tian Y, Yuan X, Niu X, Nie S, et al. Microglia Process \u03b1-Synuclein Fibrils and Enhance their Pathogenicity in a TREM2-Dependent Manner. Adv Sci (Weinh). 2025;12:e2413451.","journal-title":"Adv Sci (Weinh)"},{"key":"3083_CR62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41420-025-02538-1","volume":"11","author":"B Zhu","year":"2025","unstructured":"Zhu B, Feng J, Liang X, Fu Z, Liao M, Deng T, Wang K, Xie J, Chi J, Yang L, et al. TREM2 deficiency exacerbates cognitive impairment by aggravating \u03b1-Synuclein-induced lysosomal dysfunction in Parkinson\u2019s disease. Cell Death Discov. 2025;11:243.","journal-title":"Cell Death Discov"},{"key":"3083_CR63","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/eji.200636837","volume":"37","author":"L Piccio","year":"2007","unstructured":"Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, Colonna M, Panina-Bordignon P. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol. 2007;37:1290\u2013301.","journal-title":"Eur J Immunol"},{"key":"3083_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12264-023-01094-x","volume":"40","author":"S Qu","year":"2024","unstructured":"Qu S, Hu S, Xu H, Wu Y, Ming S, Zhan X, Wang C, Huang X. TREM-2 Drives Development of Multiple Sclerosis by Promoting Pathogenic Th17 Polarization. Neurosci Bull. 2024;40:17\u201334.","journal-title":"Neurosci Bull"},{"key":"3083_CR65","doi-asserted-by":"publisher","first-page":"1739875","DOI":"10.3389\/fimmu.2026.1739875","volume":"17","author":"T Wang","year":"2026","unstructured":"Wang T, Liu X, Wang X, Hua F, Yan L. TREM2 and microglial immunity in Alzheimer\u2019s disease: mechanisms, genetics, and therapeutic opportunities. Front Immunol. 2026;17:1739875.","journal-title":"Front Immunol"},{"key":"3083_CR66","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/10738584241254118","volume":"31","author":"Q Shi","year":"2025","unstructured":"Shi Q, Gutierrez RA, Bhat MA. Microglia, Trem2, and Neurodegeneration. Neuroscientist. 2025;31:159\u201376.","journal-title":"Neuroscientist"},{"key":"3083_CR67","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ. Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741\u201366.","journal-title":"Physiol Rev"},{"key":"3083_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"3083_CR69","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"CYD Lee","year":"2018","unstructured":"Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X, Wang N, Zhao Y, Park CS, Cooper Y, et al. Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer\u2019s Disease Models. Neuron. 2018;97:1032\u2013e10481035.","journal-title":"Neuron"},{"key":"3083_CR70","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41593-024-01620-8","volume":"27","author":"N Rachmian","year":"2024","unstructured":"Rachmian N, Medina S, Cherqui U, Akiva H, Deitch D, Edilbi D, Croese T, Salame TM, Ramos JMP, Cahalon L, et al. Identification of senescent, TREM2-expressing microglia in aging and Alzheimer\u2019s disease model mouse brain. Nat Neurosci. 2024;27:1116\u201324.","journal-title":"Nat Neurosci"},{"key":"3083_CR71","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M. TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron. 2016;91:328\u201340.","journal-title":"Neuron"},{"key":"3083_CR72","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/0-387-23226-5_16","volume":"38","author":"GP Eckert","year":"2005","unstructured":"Eckert GP, Wood WG, M\u00fcller WE. Membrane disordering effects of beta-amyloid peptides. Subcell Biochem. 2005;38:319\u201337.","journal-title":"Subcell Biochem"},{"key":"3083_CR73","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1002\/alz.14124","volume":"20","author":"HB Dean","year":"2024","unstructured":"Dean HB, Greer RA, Yang SZ, Elston DS, Brett TJ, Roberson ED, Song Y. Multimerization of TREM2 is impaired by Alzheimer\u2019s disease-associated variants. Alzheimers Dement. 2024;20:6332\u201350.","journal-title":"Alzheimers Dement"},{"key":"3083_CR74","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z, Huang R, Wang D, Li X, Wu L, et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med. 2017;214:597\u2013607.","journal-title":"J Exp Med"},{"key":"3083_CR75","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi Y, Liu CC, Painter MM, Chen XF, Verbeeck C, Zheng H, Li X, Rademakers R, Kang SS, Xu H, et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). J Biol Chem. 2015;290:26043\u201350.","journal-title":"J Biol Chem"},{"key":"3083_CR76","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","volume":"290","author":"CC Bailey","year":"2015","unstructured":"Bailey CC, DeVaux LB, Farzan M. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E. J Biol Chem. 2015;290:26033\u201342.","journal-title":"J Biol Chem"},{"key":"3083_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12974-017-0835-4","volume":"14","author":"C Jendresen","year":"2017","unstructured":"Jendresen C, \u00c5rskog V, Daws MR, Nilsson LN. The Alzheimer\u2019s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway. J Neuroinflammation. 2017;14:59.","journal-title":"J Neuroinflammation"},{"key":"3083_CR78","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","volume":"138","author":"A Boza-Serrano","year":"2019","unstructured":"Boza-Serrano A, Ruiz R, Sanchez-Varo R, Garc\u00eda-Revilla J, Yang Y, Jimenez-Ferrer I, Paulus A, Wennstr\u00f6m M, Vilalta A, Allendorf D, et al. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer\u2019s disease. Acta Neuropathol. 2019;138:251\u201373.","journal-title":"Acta Neuropathol"},{"key":"3083_CR79","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn.2016.7","volume":"17","author":"M Colonna","year":"2016","unstructured":"Colonna M, Wang Y. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci. 2016;17:201\u20137.","journal-title":"Nat Rev Neurosci"},{"key":"3083_CR80","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.celrep.2015.02.012","volume":"10","author":"MA Burguillos","year":"2015","unstructured":"Burguillos MA, Svensson M, Schulte T, Boza-Serrano A, Garcia-Quintanilla A, Kavanagh E, Santiago M, Viceconte N, Oliva-Martin MJ, Osman AM, et al. Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. Cell Rep. 2015;10:1626\u201338.","journal-title":"Cell Rep"},{"key":"3083_CR81","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1038\/s41467-023-39077-1","volume":"14","author":"G Sideris-Lampretsas","year":"2023","unstructured":"Sideris-Lampretsas G, Oggero S, Zeboudj L, Silva R, Bajpai A, Dharmalingam G, Collier DA, Malcangio M. Galectin-3 activates spinal microglia to induce inflammatory nociception in wild type but not in mice modelling Alzheimer\u2019s disease. Nat Commun. 2023;14:3579.","journal-title":"Nat Commun"},{"key":"3083_CR82","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41419-023-05897-8","volume":"14","author":"ZY Zhou","year":"2023","unstructured":"Zhou ZY, Chang TF, Lin ZB, Jing YT, Wen LS, Niu YL, Bai Q, Guo CM, Sun JX, Wang YS, Dou GR. Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via Notch inhibition by competitively binding to Jag1. Cell Death Dis. 2023;14:380.","journal-title":"Cell Death Dis"},{"key":"3083_CR83","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.15252\/embr.201743922","volume":"18","author":"F Mazaheri","year":"2017","unstructured":"Mazaheri F, Snaidero N, Kleinberger G, Madore C, Daria A, Werner G, Krasemann S, Capell A, Tr\u00fcmbach D, Wurst W, et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep. 2017;18:1186\u201398.","journal-title":"EMBO Rep"},{"key":"3083_CR84","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, Cereghetti G, McGinty D, Anselmo A, Sadreyev RI, et al. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer\u2019s Disease. Neuron. 2019;103:820\u2013e835827.","journal-title":"Neuron"},{"key":"3083_CR85","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nn.4126","volume":"18","author":"G Chan","year":"2015","unstructured":"Chan G, White CC, Winn PA, Cimpean M, Replogle JM, Glick LR, Cuerdon NE, Ryan KJ, Johnson KA, Schneider JA, et al. CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci. 2015;18:1556\u20138.","journal-title":"Nat Neurosci"},{"key":"3083_CR86","doi-asserted-by":"publisher","first-page":"e70231","DOI":"10.1002\/alz.70231","volume":"21","author":"EJ Messenger","year":"2025","unstructured":"Messenger EJ, Baar SA, Bedford LM, Tsai AP, Lin PB, Ferguson CA, Xu G, Wallace A, Landreth GE, Lamb BT, Bissel SJ. PLCG2 modulates TREM2 expression and signaling in response to Alzheimer\u2019s disease pathology. Alzheimers Dement. 2025;21:e70231.","journal-title":"Alzheimers Dement"},{"key":"3083_CR87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature09615","volume":"468","author":"RM Ransohoff","year":"2010","unstructured":"Ransohoff RM, Cardona AE. The myeloid cells of the central nervous system parenchyma. Nature. 2010;468:253\u201362.","journal-title":"Nature"},{"key":"3083_CR88","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.molcel.2008.06.023","volume":"31","author":"W Zou","year":"2008","unstructured":"Zou W, Reeve JL, Liu Y, Teitelbaum SL, Ross FP. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol Cell. 2008;31:422\u201331.","journal-title":"Mol Cell"},{"key":"3083_CR89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, Philipp S, Albay R 3rd, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, Glabe CG. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2018;13:11.","journal-title":"Mol Neurodegener"},{"key":"3083_CR90","doi-asserted-by":"publisher","first-page":"e13108","DOI":"10.1111\/bpa.13108","volume":"33","author":"A Fracassi","year":"2023","unstructured":"Fracassi A, Marcatti M, Tumurbaatar B, Woltjer R, Moreno S, Taglialatela G. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer\u2019s neuropathology. Brain Pathol. 2023;33:e13108.","journal-title":"Brain Pathol"},{"key":"3083_CR91","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fncel.2019.00457","volume":"13","author":"H Yao","year":"2019","unstructured":"Yao H, Coppola K, Schweig JE, Crawford F, Mullan M, Paris D. Distinct Signaling Pathways Regulate TREM2 Phagocytic and NF\u03baB Antagonistic Activities. Front Cell Neurosci. 2019;13:457.","journal-title":"Front Cell Neurosci"},{"key":"3083_CR92","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/ni.1744","volume":"10","author":"K Otero","year":"2009","unstructured":"Otero K, Turnbull IR, Poliani PL, Vermi W, Cerutti E, Aoshi T, Tassi I, Takai T, Stanley SL, Miller M, et al. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol. 2009;10:734\u201343.","journal-title":"Nat Immunol"},{"key":"3083_CR93","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molimm.2020.12.035","volume":"131","author":"R Akhter","year":"2021","unstructured":"Akhter R, Shao Y, Formica S, Khrestian M, Bekris LM. TREM2 alters the phagocytic, apoptotic and inflammatory response to A\u03b2(42) in HMC3 cells. Mol Immunol. 2021;131:171\u20139.","journal-title":"Mol Immunol"},{"key":"3083_CR94","doi-asserted-by":"publisher","first-page":"24968","DOI":"10.1038\/s41598-025-09563-1","volume":"15","author":"L Zhu","year":"2025","unstructured":"Zhu L, Zhou T, Wu L, Zhu X, Chen L, Zhang M, Zhou J, Wang F. Microglial exosome TREM2 ameliorates ferroptosis and neuroinflammation in alzheimer\u2019s disease by activating the Wnt\/\u03b2-catenin signaling. Sci Rep. 2025;15:24968.","journal-title":"Sci Rep"},{"key":"3083_CR95","doi-asserted-by":"publisher","first-page":"20862","DOI":"10.18632\/aging.104104","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lin Y, Wang L, Zhan H, Luo X, Zeng Y, Wu W, Zhang X, Wang F. TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K\/AKT\/FoxO3a signaling pathway in Alzheimer\u2019s disease mice. Aging. 2020;12:20862\u201379.","journal-title":"Aging"},{"key":"3083_CR96","doi-asserted-by":"publisher","first-page":"115205","DOI":"10.1016\/j.expneurol.2025.115205","volume":"388","author":"XQ Peng","year":"2025","unstructured":"Peng XQ, Guo HS, Zhang X, Wu XY, Ruganzu JB, Wu SD, Zhao MT, Li L, Yang Y, Ji SF, et al. TREM2 promotes hippocampal neurogenesis through regulating microglial M2 polarization in APP\/PS1 mice. Exp Neurol. 2025;388:115205.","journal-title":"Exp Neurol"},{"key":"3083_CR97","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1523\/JNEUROSCI.2427-21.2022","volume":"42","author":"Q Shi","year":"2022","unstructured":"Shi Q, Chang C, Saliba A, Bhat MA. Microglial mTOR Activation Upregulates Trem2 and Enhances \u03b2-Amyloid Plaque Clearance in the 5XFAD Alzheimer\u2019s Disease Model. J Neurosci. 2022;42:5294\u2013313.","journal-title":"J Neurosci"},{"key":"3083_CR98","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bbi.2019.07.004","volume":"81","author":"Q Xu","year":"2019","unstructured":"Xu Q, Xu W, Cheng H, Yuan H, Tan X. Efficacy and mechanism of cGAMP to suppress Alzheimer\u2019s disease by elevating TREM2. Brain Behav Immun. 2019;81:495\u2013508.","journal-title":"Brain Behav Immun"},{"key":"3083_CR99","doi-asserted-by":"publisher","first-page":"104688","DOI":"10.1016\/j.jbc.2023.104688","volume":"299","author":"Y Lu","year":"2023","unstructured":"Lu Y, Huang X, Liang W, Li Y, Xing M, Pan W, Zhang Y, Wang Z, Song W. Regulation of TREM2 expression by transcription factor YY1 and its protective effect against Alzheimer\u2019s disease. J Biol Chem. 2023;299:104688.","journal-title":"J Biol Chem"},{"key":"3083_CR100","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1007\/s12035-022-02827-1","volume":"59","author":"L Zhang","year":"2022","unstructured":"Zhang L, Dong W, Ma Y, Bai L, Zhang X, Sun C, Li J, Zhang L. Pon1 Deficiency Promotes Trem2 Pathway-Mediated Microglial Phagocytosis and Inhibits Pro-inflammatory Cytokines Release In Vitro and In Vivo. Mol Neurobiol. 2022;59:4612\u201329.","journal-title":"Mol Neurobiol"},{"key":"3083_CR101","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12974-024-03314-1","volume":"21","author":"Y Yang","year":"2024","unstructured":"Yang Y, Shi G, Ge Y, Huang S, Cui N, Tan L, Liu R, Yang X. Accumulated BCAAs and BCKAs contribute to the HFD-induced deterioration of Alzheimer\u2019s disease via a dysfunctional TREM2-related reduction in microglial \u03b2-amyloid clearance. J Neuroinflammation. 2024;21:327.","journal-title":"J Neuroinflammation"},{"key":"3083_CR102","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnagi.2016.00140","volume":"8","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Jaber V, Lukiw WJ. Over-Expressed Pathogenic miRNAs in Alzheimer\u2019s Disease (AD) and Prion Disease (PrD) Drive Deficits in TREM2-Mediated A\u03b242 Peptide Clearance. Front Aging Neurosci. 2016;8:140.","journal-title":"Front Aging Neurosci"},{"key":"3083_CR103","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molimm.2021.12.018","volume":"142","author":"JB Ruganzu","year":"2022","unstructured":"Ruganzu JB, Peng X, He Y, Wu X, Zheng Q, Ding B, Lin C, Guo H, Yang Z, Zhang X, Yang W. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer\u2019s disease. Mol Immunol. 2022;142:22\u201336.","journal-title":"Mol Immunol"},{"key":"3083_CR104","doi-asserted-by":"publisher","unstructured":"Zhao A, Jiao Y, Ye G, Kang W, Tan L, Li Y, Deng Y, Liu J. Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer\u2019s disease. J Clin Invest. 2022;132. https:\/\/doi.org\/10.1172\/JCI158708.","DOI":"10.1172\/JCI158708"},{"key":"3083_CR105","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas-Rodr\u00edguez","year":"2022","unstructured":"Morenas-Rodr\u00edguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Su\u00e1rez-Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study. Lancet Neurol. 2022;21:329\u201341.","journal-title":"Lancet Neurol"},{"key":"3083_CR106","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-015-0040-9","volume":"10","author":"MM Painter","year":"2015","unstructured":"Painter MM, Atagi Y, Liu CC, Rademakers R, Xu H, Fryer JD, Bu G. TREM2 in CNS homeostasis and neurodegenerative disease. Mol Neurodegener. 2015;10:43.","journal-title":"Mol Neurodegener"},{"key":"3083_CR107","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.jmb.2017.04.004","volume":"429","author":"DL Kober","year":"2017","unstructured":"Kober DL, Brett TJ. TREM2-Ligand Interactions in Health and Disease. J Mol Biol. 2017;429:1607\u201329.","journal-title":"J Mol Biol"},{"key":"3083_CR108","doi-asserted-by":"publisher","unstructured":"Arsenault R, Marshall S, Salois P, Li Q, Zhang W. sTREM2 Differentially Affects Cytokine Expression in Myeloid-Derived Cell Models via MAPK-JNK Signaling Pathway. Biology (Basel). 2024;13. https:\/\/doi.org\/10.3390\/biology13020087.","DOI":"10.3390\/biology13020087"},{"key":"3083_CR109","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13024-023-00599-3","volume":"18","author":"W Qiao","year":"2023","unstructured":"Qiao W, Chen Y, Zhong J, Madden BJ, Charlesworth CM, Martens YA, Liu CC, Knight J, Ikezu TC, Kurti A, et al. Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology. Mol Neurodegener. 2023;18:8.","journal-title":"Mol Neurodegener"},{"key":"3083_CR110","doi-asserted-by":"publisher","unstructured":"Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, Li Z, Del-Aguila JL, Dube U, Farias FG, et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Sci Transl Med. 2019;11. https:\/\/doi.org\/10.1126\/scitranslmed.aau2291.","DOI":"10.1126\/scitranslmed.aau2291"},{"key":"3083_CR111","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12974-025-03420-8","volume":"22","author":"K Chen","year":"2025","unstructured":"Chen K, Li F, Zhang S, Chen Y, Ikezu TC, Li Z, Martens YA, Qiao W, Meneses A, Zhu Y, et al. Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. J Neuroinflammation. 2025;22:93.","journal-title":"J Neuroinflammation"},{"key":"3083_CR112","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.neurobiolaging.2015.08.019","volume":"36","author":"T Jiang","year":"2015","unstructured":"Jiang T, Tan L, Zhu XC, Zhou JS, Cao L, Tan MS, Wang HF, Chen Q, Zhang YD, Yu JT. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice. Neurobiol Aging. 2015;36:3176\u201386.","journal-title":"Neurobiol Aging"},{"key":"3083_CR113","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40478-021-01251-1","volume":"9","author":"AT Delizannis","year":"2021","unstructured":"Delizannis AT, Nonneman A, Tsering W, De Bondt A, Van den Wyngaert I, Zhang B, Meymand E, Olufemi MF, Koivula P, Maimaiti S, et al. Effects of microglial depletion and TREM2 deficiency on A\u03b2 plaque burden and neuritic plaque tau pathology in 5XFAD mice. Acta Neuropathol Commun. 2021;9:150.","journal-title":"Acta Neuropathol Commun"},{"key":"3083_CR114","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.1073\/pnas.1811411115","volume":"115","author":"FA Sayed","year":"2018","unstructured":"Sayed FA, Telpoukhovskaia M, Kodama L, Li Y, Zhou Y, Le D, Hauduc A, Ludwig C, Gao F, Clelland C, et al. Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. Proc Natl Acad Sci U S A. 2018;115:10172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3083_CR115","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller SM, McCray TJ, Allan K, Formica SV, Xu G, Wilson G, Kokiko-Cochran ON, Crish SD, Lasagna-Reeves CA, Ransohoff RM, et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener. 2017;12:74.","journal-title":"Mol Neurodegener"},{"key":"3083_CR116","doi-asserted-by":"publisher","unstructured":"Gratuze M, Chen Y, Parhizkar S, Jain N, Strickland MR, Serrano JR, Colonna M, Ulrich JD, Holtzman DM. Activated microglia mitigate A\u03b2-associated tau seeding and spreading. J Exp Med. 2021;218. https:\/\/doi.org\/10.1084\/jem.20210542.","DOI":"10.1084\/jem.20210542"},{"key":"3083_CR117","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10753-018-0735-5","volume":"41","author":"T Jiang","year":"2018","unstructured":"Jiang T, Zhang YD, Gao Q, Ou Z, Gong PY, Shi JQ, Wu L, Zhou JS. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response. Inflammation. 2018;41:811\u201323.","journal-title":"Inflammation"},{"key":"3083_CR118","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, Luo W, Colonna M, Baddeley D, Grutzendler J. TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron"},{"key":"3083_CR119","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, Rezzonico MG, Imperio J, Lalehzadeh G, Huntley MA, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron. 2021;109:1283\u2013e13011286.","journal-title":"Neuron"},{"key":"3083_CR120","doi-asserted-by":"publisher","unstructured":"Jain N, Lewis CA, Ulrich JD, Holtzman DM. Chronic TREM2 activation exacerbates A\u03b2-associated tau seeding and spreading. J Exp Med. 2023;220. https:\/\/doi.org\/10.1084\/jem.20220654.","DOI":"10.1084\/jem.20220654"},{"key":"3083_CR121","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, Ulrich JD, Finn MB, Stewart FR, Koscal LJ, Remolina Serrano J, Robinson GO, Anderson E, Colonna M, Holtzman DM. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci U S A. 2017;114:11524\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3083_CR122","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523\u20137.","journal-title":"Nature"},{"key":"3083_CR123","doi-asserted-by":"publisher","first-page":"eabe3947","DOI":"10.1126\/scitranslmed.abe3947","volume":"13","author":"FA Sayed","year":"2021","unstructured":"Sayed FA, Kodama L, Fan L, Carling GK, Udeochu JC, Le D, Li Q, Zhou L, Wong MY, Horowitz R, et al. AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation. Sci Transl Med. 2021;13:eabe3947.","journal-title":"Sci Transl Med"},{"key":"3083_CR124","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1016\/j.celrep.2018.05.048","volume":"23","author":"A Villa","year":"2018","unstructured":"Villa A, Gelosa P, Castiglioni L, Cimino M, Rizzi N, Pepe G, Lolli F, Marcello E, Sironi L, Vegeto E, Maggi A. Sex-Specific Features of Microglia from Adult Mice. Cell Rep. 2018;23:3501\u201311.","journal-title":"Cell Rep"},{"key":"3083_CR125","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1016\/j.celrep.2018.08.001","volume":"24","author":"D Guneykaya","year":"2018","unstructured":"Guneykaya D, Ivanov A, Hernandez DP, Haage V, Wojtas B, Meyer N, Maricos M, Jordan P, Buonfiglioli A, Gielniewski B, et al. Transcriptional and Translational Differences of Microglia from Male and Female Brains. Cell Rep. 2018;24:2773\u2013e27832776.","journal-title":"Cell Rep"},{"key":"3083_CR126","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1172\/JCI138179","volume":"130","author":"M Gratuze","year":"2020","unstructured":"Gratuze M, Leyns CE, Sauerbeck AD, St-Pierre MK, Xiong M, Kim N, Serrano JR, Tremblay M, Kummer TT, Colonna M, et al. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J Clin Invest. 2020;130:4954\u201368.","journal-title":"J Clin Invest"},{"key":"3083_CR127","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1016\/j.neuron.2024.09.006","volume":"112","author":"GK Carling","year":"2024","unstructured":"Carling GK, Fan L, Foxe NR, Norman K, Wong MY, Zhu D, Corona C, Razzoli A, Yu F, Yarahmady A, et al. Alzheimer\u2019s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model. Neuron. 2024;112:3877\u2013e38963878.","journal-title":"Neuron"},{"key":"3083_CR128","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, Manis M, Colonna M, Lee VMY, Ulrich JD, Holtzman DM. TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci. 2019;22:1217\u201322.","journal-title":"Nat Neurosci"},{"key":"3083_CR129","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0197-4580(00)00157-3","volume":"21","author":"CL Weaver","year":"2000","unstructured":"Weaver CL, Espinoza M, Kress Y, Davies P. Conformational change as one of the earliest alterations of tau in Alzheimer\u2019s disease. Neurobiol Aging. 2000;21:719\u201327.","journal-title":"Neurobiol Aging"},{"key":"3083_CR130","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00401-023-02564-2","volume":"145","author":"RL Winfree","year":"2023","unstructured":"Winfree RL, Seto M, Dumitrescu L, Menon V, De Jager P, Wang Y, Schneider J, Bennett DA, Jefferson AL, Hohman TJ. TREM2 gene expression associations with Alzheimer\u2019s disease neuropathology are region-specific: implications for cortical versus subcortical microglia. Acta Neuropathol. 2023;145:733\u201347.","journal-title":"Acta Neuropathol"},{"key":"3083_CR131","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Genetics and Pathogenesis of Parkinson\u2019s Syndrome. Annu Rev Pathol. 2023;18:95\u2013121.","journal-title":"Annu Rev Pathol"},{"key":"3083_CR132","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-8-19","volume":"8","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease. Mol Neurodegener. 2013;8:19.","journal-title":"Mol Neurodegener"},{"key":"3083_CR133","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jalz.2014.12.009","volume":"11","author":"CM Lill","year":"2015","unstructured":"Lill CM, Rengmark A, Pihlstr\u00f8m L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, et al. The role of TREM2 R47H as a risk factor for Alzheimer\u2019s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson\u2019s disease. Alzheimers Dement. 2015;11:1407\u201316.","journal-title":"Alzheimers Dement"},{"key":"3083_CR134","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li Y, Zhao C, Luo F, Liu Z, Gui X, Luo Z, Zhang X, Li D, Liu C, Li X. Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy. Cell Res. 2018;28:897\u2013903.","journal-title":"Cell Res"},{"key":"3083_CR135","doi-asserted-by":"publisher","unstructured":"Guerrero-Ferreira R, Taylor NM, Mona D, Ringler P, Lauer ME, Riek R, Britschgi M, Stahlberg H. Cryo-EM structure of alpha-synuclein fibrils. Elife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.36402.","DOI":"10.7554\/eLife.36402"},{"key":"3083_CR136","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1096\/fj.201900992R","volume":"33","author":"Y Guo","year":"2019","unstructured":"Guo Y, Wei X, Yan H, Qin Y, Yan S, Liu J, Zhao Y, Jiang F, Lou H. TREM2 deficiency aggravates \u03b1-synuclein-induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models. Faseb j. 2019;33:12164\u201374.","journal-title":"Faseb j"},{"key":"3083_CR137","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbrc.2018.03.226","volume":"499","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Feng S, Nie K, Li Y, Gao Y, Gan R, Wang L, Li B, Sun X, Wang L, Zhang Y. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson\u2019s disease. Biochem Biophys Res Commun. 2018;499:797\u2013802.","journal-title":"Biochem Biophys Res Commun"},{"key":"3083_CR138","doi-asserted-by":"publisher","first-page":"113446","DOI":"10.1016\/j.intimp.2024.113446","volume":"143","author":"S Yin","year":"2024","unstructured":"Yin S, Chi X, Wan F, Li Y, Zhou Q, Kou L, Sun Y, Wu J, Zou W, Wang Y, et al. TREM2 signaling in Parkinson\u2019s disease: Regulation of microglial function and \u03b1-synuclein pathology. Int Immunopharmacol. 2024;143:113446.","journal-title":"Int Immunopharmacol"},{"key":"3083_CR139","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/jnc.15299","volume":"157","author":"Q Lv","year":"2021","unstructured":"Lv Q, Zhong Z, Hu B, Yan S, Yan Y, Zhang J, Shi T, Jiang L, Li W, Huang W. MicroRNA-3473b regulates the expression of TREM2\/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease. J Neurochem. 2021;157:599\u2013610.","journal-title":"J Neurochem"},{"key":"3083_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.07.009","volume":"311","author":"M Hebron","year":"2017","unstructured":"Hebron M, Peyton M, Liu X, Gao X, Wang R, Lonskaya I, Moussa CE. Discoidin domain receptor inhibition reduces neuropathology and attenuates inflammation in neurodegeneration models. J Neuroimmunol. 2017;311:1\u20139.","journal-title":"J Neuroimmunol"},{"key":"3083_CR141","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/eji.201141679","volume":"42","author":"H Ito","year":"2012","unstructured":"Ito H, Hamerman JA. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol. 2012;42:176\u201385.","journal-title":"Eur J Immunol"},{"key":"3083_CR142","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","volume":"302","author":"M Ren","year":"2018","unstructured":"Ren M, Guo Y, Wei X, Yan S, Qin Y, Zhang X, Jiang F, Lou H. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease. Exp Neurol. 2018;302:205\u201313.","journal-title":"Exp Neurol"},{"key":"3083_CR143","doi-asserted-by":"publisher","first-page":"e14630","DOI":"10.1111\/cns.14630","volume":"30","author":"H Liang","year":"2024","unstructured":"Liang H, Liu P, Wang Z, Xiong H, Yin C, Zhao D, Wu C, Chen L. TREM2 gene induces differentiation of induced pluripotent stem cells into dopaminergic neurons and promotes neuronal repair via TGF-\u03b2 activation in 6-OHDA-lesioned mouse model of Parkinson\u2019s disease. CNS Neurosci Ther. 2024;30:e14630.","journal-title":"CNS Neurosci Ther"},{"key":"3083_CR144","doi-asserted-by":"publisher","first-page":"745815","DOI":"10.3389\/fnins.2021.745815","volume":"15","author":"W Huang","year":"2021","unstructured":"Huang W, Lv Q, Xiao Y, Zhong Z, Hu B, Yan S, Yan Y, Zhang J, Shi T, Jiang L, et al. Triggering Receptor Expressed on Myeloid Cells 2 Protects Dopaminergic Neurons by Promoting Autophagy in the Inflammatory Pathogenesis of Parkinson\u2019s Disease. Front Neurosci. 2021;15:745815.","journal-title":"Front Neurosci"},{"key":"3083_CR145","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2017.01.010","volume":"53","author":"S Belloli","year":"2017","unstructured":"Belloli S, Pannese M, Buonsanti C, Maiorino C, Di Grigoli G, Carpinelli A, Monterisi C, Moresco RM, Panina-Bordignon P. Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice. Neurobiol Aging. 2017;53:159\u201368.","journal-title":"Neurobiol Aging"},{"key":"3083_CR146","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/brain\/awaa021","volume":"143","author":"EN Wilson","year":"2020","unstructured":"Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, Channappa D, Minhas PS, Mhatre SD, Plowey ED, et al. Soluble TREM2 is elevated in Parkinson\u2019s disease subgroups with increased CSF tau. Brain. 2020;143:932\u201343.","journal-title":"Brain"},{"key":"3083_CR147","doi-asserted-by":"publisher","first-page":"892493","DOI":"10.3389\/fnagi.2022.892493","volume":"14","author":"Q Qin","year":"2022","unstructured":"Qin Q, Wan H, Wang D, Li J, Qu Y, Zhao J, Li J, Xue Z. The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson\u2019s Disease: Analysis of the PPMI Cohort. Front Aging Neurosci. 2022;14:892493.","journal-title":"Front Aging Neurosci"},{"key":"3083_CR148","doi-asserted-by":"publisher","first-page":"753210","DOI":"10.3389\/fnagi.2021.753210","volume":"13","author":"M Mo","year":"2021","unstructured":"Mo M, Tang Y, Wei L, Qiu J, Peng G, Lin Y, Zhou M, Dai W, Zhang Z, Chen X, et al. Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson\u2019s Disease. Front Aging Neurosci. 2021;13:753210.","journal-title":"Front Aging Neurosci"},{"key":"3083_CR149","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41531-025-01247-x","volume":"12","author":"K Hou","year":"2026","unstructured":"Hou K, An Z, Xu Y, Wang J, Zhou M, Liu Y, Zhu X, Wei J. Parkinson\u2019s disease: spatiotemporal regulation and therapeutic prospects of TREM2-mediated microglial responses. NPJ Parkinsons Dis. 2026;12:37.","journal-title":"NPJ Parkinsons Dis"},{"key":"3083_CR150","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","volume":"25","author":"MS Woo","year":"2024","unstructured":"Woo MS, Engler JB, Friese MA. The neuropathobiology of multiple sclerosis. Nat Rev Neurosci. 2024;25:493\u2013513.","journal-title":"Nat Rev Neurosci"},{"key":"3083_CR151","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/awx113","volume":"140","author":"T Zrzavy","year":"2017","unstructured":"Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, Lassmann H. Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis. Brain. 2017;140:1900\u201313.","journal-title":"Brain"},{"key":"3083_CR152","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/brain\/awn217","volume":"131","author":"L Piccio","year":"2008","unstructured":"Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker J 2nd, Naismith RT, Panina-Bordignon P, Passini N, et al. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain. 2008;131:3081\u201391.","journal-title":"Brain"},{"key":"3083_CR153","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/00207454.2016.1264072","volume":"127","author":"J Han","year":"2017","unstructured":"Han J, Wang M, Ren M, Lou H. Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases. Int J Neurosci. 2017;127:368\u201375.","journal-title":"Int J Neurosci"},{"key":"3083_CR154","doi-asserted-by":"publisher","first-page":"115071","DOI":"10.1016\/j.expneurol.2024.115071","volume":"384","author":"M Farzan","year":"2025","unstructured":"Farzan M, Saberi-Rounkian M, Asadi-Rizi A, Heidari Z, Farzan M, Fathi M, Aghaei A, Azadegan-Dehkordi F, Bagheri N. The emerging role of the microglia triggering receptor expressed on myeloid cells (TREM) 2 in multiple sclerosis. Exp Neurol. 2025;384:115071.","journal-title":"Exp Neurol"},{"key":"3083_CR155","doi-asserted-by":"publisher","unstructured":"Gouna G, Klose C, Bosch-Queralt M, Liu L, Gokce O, Schifferer M, Cantuti-Castelvetri L, Simons M. TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination. J Exp Med. 2021;218. https:\/\/doi.org\/10.1084\/jem.20210227.","DOI":"10.1084\/jem.20210227"},{"key":"3083_CR156","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/glia.24335","volume":"71","author":"Y Wang","year":"2023","unstructured":"Wang Y, Kyauk RV, Shen YA, Xie L, Reichelt M, Lin H, Jiang Z, Ngu H, Shen K, Greene JJ, et al. TREM2-dependent microglial function is essential for remyelination and subsequent neuroprotection. Glia. 2023;71:1247\u201358.","journal-title":"Glia"},{"key":"3083_CR157","doi-asserted-by":"publisher","first-page":"e2426786122","DOI":"10.1073\/pnas.2426786122","volume":"122","author":"J Hou","year":"2025","unstructured":"Hou J, Magliozzi R, Chen Y, Wu J, Wulf J 2nd, Strout G, Fang X, Colonna M. Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination. Proc Natl Acad Sci U S A. 2025;122:e2426786122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3083_CR158","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00401-015-1388-1","volume":"129","author":"C Cantoni","year":"2015","unstructured":"Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, Yuede CM, Galimberti D, Olivecrona G, Klein RS, et al. TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol. 2015;129:429\u201347.","journal-title":"Acta Neuropathol"},{"key":"3083_CR159","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, Llapashtica C, Wang J, Kim DJ, Xia D, et al. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron. 2020;105:837\u2013e854839.","journal-title":"Neuron"},{"key":"3083_CR160","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1172\/JCI77983","volume":"125","author":"PL Poliani","year":"2015","unstructured":"Poliani PL, Wang Y, Fontana E, Robinette ML, Yamanishi Y, Gilfillan S, Colonna M. TREM2 sustains microglial expansion during aging and response to demyelination. J Clin Invest. 2015;125:2161\u201370.","journal-title":"J Clin Invest"},{"key":"3083_CR161","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","volume":"140","author":"F Cignarella","year":"2020","unstructured":"Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, Manis M, Ibrahim A, Deng L, Benitez BA, et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. 2020;140:513\u201334.","journal-title":"Acta Neuropathol"},{"key":"3083_CR162","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1371\/journal.pmed.0040124","volume":"4","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 2007;4:e124.","journal-title":"PLoS Med"},{"key":"3083_CR163","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","volume":"24","author":"Y Dong","year":"2021","unstructured":"Dong Y, D\u2019Mello C, Pinsky W, Lozinski BM, Kaushik DK, Ghorbani S, Moezzi D, Brown D, Melo FC, Zandee S, et al. Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nat Neurosci. 2021;24:489\u2013503.","journal-title":"Nat Neurosci"},{"key":"3083_CR164","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ana.25691","volume":"87","author":"E Oldoni","year":"2020","unstructured":"Oldoni E, Smets I, Mallants K, Vandebergh M, Van Horebeek L, Poesen K, Dupont P, Dubois B, Goris A. CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity. Ann Neurol. 2020;87:633\u201345.","journal-title":"Ann Neurol"},{"key":"3083_CR165","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1086\/342259","volume":"71","author":"J Paloneva","year":"2002","unstructured":"Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, Bianchin M, Bird T, Miranda R, Salmaggi A, et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet. 2002;71:656\u201362.","journal-title":"Am J Hum Genet"},{"key":"3083_CR166","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/TACG.S245029","volume":"14","author":"DW Sirkis","year":"2021","unstructured":"Sirkis DW, Bonham LW, Yokoyama JS. The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia. Appl Clin Genet. 2021;14:195\u2013207.","journal-title":"Appl Clin Genet"},{"key":"3083_CR167","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/77153","volume":"25","author":"J Paloneva","year":"2000","unstructured":"Paloneva J, Kestil\u00e4 M, Wu J, Salminen A, B\u00f6hling T, Ruotsalainen V, Hakola P, Bakker AB, Phillips JH, Pekkarinen P, et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet. 2000;25:357\u201361.","journal-title":"Nat Genet"},{"key":"3083_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","volume":"74","author":"F Jadidi-Niaragh","year":"2011","unstructured":"Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol. 2011;74:1\u201313.","journal-title":"Scand J Immunol"},{"key":"3083_CR169","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jneuroim.2019.04.011","volume":"332","author":"AF Setiadi","year":"2019","unstructured":"Setiadi AF, Abbas AR, Jeet S, Wong K, Bischof A, Peng I, Lee J, Bremer M, Eggers EL, DeVoss J, et al. IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis. J Neuroimmunol. 2019;332:147\u201354.","journal-title":"J Neuroimmunol"},{"key":"3083_CR170","first-page":"205521732110197","volume":"7","author":"ZA Ioannides","year":"2021","unstructured":"Ioannides ZA, Csurhes PA, Swayne A, Foubert P, Aftab BT, Pender MP. Correlations between macrophage\/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis. Mult Scler J Exp Transl Clin. 2021;7:20552173211019772.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"3083_CR171","doi-asserted-by":"publisher","unstructured":"Azzolini F, Gilio L, Pavone L, Iezzi E, Dolcetti E, Bruno A, Buttari F, Musella A, Mandolesi G, Guadalupi L, et al. Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis. Biomolecules. 2022;12. https:\/\/doi.org\/10.3390\/biom12020222.","DOI":"10.3390\/biom12020222"},{"key":"3083_CR172","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fneur.2019.00280","volume":"10","author":"A Abdelhak","year":"2019","unstructured":"Abdelhak A, Hottenrott T, Morenas-Rodr\u00edguez E, Su\u00e1rez-Calvet M, Zettl UK, Haass C, Meuth SG, Rauer S, Otto M, Tumani H, Huss A. Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker? Front Neurol. 2019;10:280.","journal-title":"Front Neurol"},{"key":"3083_CR173","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197\u2013206.","journal-title":"Nature"},{"key":"3083_CR174","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40035-023-00377-7","volume":"12","author":"L Zhu","year":"2023","unstructured":"Zhu L, Li S, Li XJ, Yin P. Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges. Transl Neurodegener. 2023;12:46.","journal-title":"Transl Neurodegener"},{"key":"3083_CR175","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s11033-021-06312-1","volume":"48","author":"V Siokas","year":"2021","unstructured":"Siokas V, Aloizou AM, Liampas I, Tsouris Z, Mentis AA, Nasios G, Papadimitriou D, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis. Mol Biol Rep. 2021;48:2601\u201310.","journal-title":"Mol Biol Rep"},{"key":"3083_CR176","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jns.2015.05.010","volume":"355","author":"X Chen","year":"2015","unstructured":"Chen X, Chen Y, Wei Q, Guo X, Cao B, Ou R, Zhao B, Shang HF. Assessment of TREM2 rs75932628 association with amyotrophic lateral sclerosis in a Chinese population. J Neurol Sci. 2015;355:193\u20135.","journal-title":"J Neurol Sci"},{"key":"3083_CR177","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","volume":"71","author":"J Cady","year":"2014","unstructured":"Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, Baloh RH, Ravits J, Simpson E, Appel SH, et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:449\u201353.","journal-title":"JAMA Neurol"},{"key":"3083_CR178","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nn.3357","volume":"16","author":"SH Kang","year":"2013","unstructured":"Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, Rothstein JD, Bergles DE. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci. 2013;16:571\u20139.","journal-title":"Nat Neurosci"},{"key":"3083_CR179","doi-asserted-by":"publisher","first-page":"102732","DOI":"10.1016\/j.pneurobio.2025.102732","volume":"247","author":"X Que","year":"2025","unstructured":"Que X, Zhang T, Liu X, Yin Y, Xia X, Gong P, Song W, Qin Q, Xu ZD, Tang Y. The role of TREM2 in myelin sheath dynamics: A comprehensive perspective from physiology to pathology. Prog Neurobiol. 2025;247:102732.","journal-title":"Prog Neurobiol"},{"key":"3083_CR180","doi-asserted-by":"publisher","unstructured":"Barbosa M, Santos M, de Sousa N, Duarte-Silva S, Vaz AR, Salgado AJ, Brites D. Intrathecal Injection of the Secretome from ALS Motor Neurons Regulated for miR-124 Expression Prevents Disease Outcomes in SOD1-G93A Mice. Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10092120.","DOI":"10.3390\/biomedicines10092120"},{"key":"3083_CR181","doi-asserted-by":"publisher","first-page":"112133","DOI":"10.1016\/j.celrep.2023.112133","volume":"42","author":"X Shu","year":"2023","unstructured":"Shu X, Wei C, Tu WY, Zhong K, Qi S, Wang A, Bai L, Zhang SX, Luo B, Xu ZZ, et al. Negative regulation of TREM2-mediated C9orf72 poly-GA clearance by the NLRP3 inflammasome. Cell Rep. 2023;42:112133.","journal-title":"Cell Rep"},{"key":"3083_CR182","doi-asserted-by":"publisher","first-page":"1515252","DOI":"10.3389\/fneur.2024.1515252","volume":"15","author":"L Jiao","year":"2024","unstructured":"Jiao L, Yang J, Wang W, Liu X, Fu Y, Fan D. sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden. Front Neurol. 2024;15:1515252.","journal-title":"Front Neurol"},{"key":"3083_CR183","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbi.2023.01.013","volume":"109","author":"I Jeric\u00f3","year":"2023","unstructured":"Jeric\u00f3 I, Vicu\u00f1a-Urriza J, Blanco-Luquin I, Macias M, Martinez-Merino L, Rold\u00e1n M, Rojas-Garcia R, Pagola-Lorz I, Carbayo A, De Luna N, et al. Profiling TREM2 expression in amyotrophic lateral sclerosis. Brain Behav Immun. 2023;109:117\u201326.","journal-title":"Brain Behav Immun"},{"key":"3083_CR184","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40478-017-0424-x","volume":"5","author":"J Cooper-Knock","year":"2017","unstructured":"Cooper-Knock J, Green C, Altschuler G, Wei W, Bury JJ, Heath PR, Wyles M, Gelsthorpe C, Highley JR, Lorente-Pons A, et al. A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2017;5:23.","journal-title":"Acta Neuropathol Commun"},{"key":"3083_CR185","doi-asserted-by":"publisher","first-page":"123112","DOI":"10.1016\/j.jns.2024.123112","volume":"463","author":"C Ros\u00e9n","year":"2024","unstructured":"Ros\u00e9n C, Mitre B, Nellg\u00e5rd B, Axelsson M, Constantinescu R, Andersen PM, Dalla K, Blennow K, Nilsson G, Zetterberg H, Ros\u00e9n H. High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS. J Neurol Sci. 2024;463:123112.","journal-title":"J Neurol Sci"},{"key":"3083_CR186","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3233\/JAD-210041","volume":"88","author":"M Stoiljkovic","year":"2022","unstructured":"Stoiljkovic M, Gutierrez KO, Kelley C, Horvath TL, Haj\u00f3s M. TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-\u03b2-Related Hippocampal Pathophysiology in Mice. J Alzheimers Dis. 2022;88:837\u201347.","journal-title":"J Alzheimers Dis"},{"key":"3083_CR187","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.bbi.2024.09.034","volume":"123","author":"DB Bosco","year":"2025","unstructured":"Bosco DB, Kremen V, Haruwaka K, Zhao S, Wang L, Ebner BA, Zheng J, Xie M, Dheer A, Perry JF, et al. Microglial TREM2 promotes phagocytic clearance of damaged neurons after status epilepticus. Brain Behav Immun. 2025;123:540\u201355.","journal-title":"Brain Behav Immun"},{"key":"3083_CR188","doi-asserted-by":"publisher","unstructured":"Bosco DB, Kremen V, Haruwaka K, Zhao S, Wang L, Ebner BA, Zheng J, Dheer A, Perry JF, Xie M et al. Impaired microglial phagocytosis promotes seizure development. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2023.12.31.573794.","DOI":"10.1101\/2023.12.31.573794"},{"key":"3083_CR189","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12264-018-0324-5","volume":"35","author":"AH Liu","year":"2019","unstructured":"Liu AH, Chu M, Wang YP. Up-Regulation of Trem2 Inhibits Hippocampal Neuronal Apoptosis and Alleviates Oxidative Stress in Epilepsy via the PI3K\/Akt Pathway in Mice. Neurosci Bull. 2019;35:471\u201385.","journal-title":"Neurosci Bull"},{"key":"3083_CR190","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s11064-021-03371-5","volume":"46","author":"H Wang","year":"2021","unstructured":"Wang H, Feng Y, Sun J, Zhang W, Han Z, Yu S, Gu Y, Cheng X, Lin Z, Na M. Methyl-CpG-Binding Domain Protein 3 Promotes Seizures by Recruiting Methyltransferase DNMT1 to Enhance TREM2 Methylation. Neurochem Res. 2021;46:2451\u201362.","journal-title":"Neurochem Res"},{"key":"3083_CR191","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11064-008-9657-1","volume":"34","author":"JC Thrash","year":"2009","unstructured":"Thrash JC, Torbett BE, Carson MJ. Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochem Res. 2009;34:38\u201345.","journal-title":"Neurochem Res"},{"key":"3083_CR192","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-201085","volume":"79","author":"E Maderna","year":"2021","unstructured":"Maderna E, Vison\u00e0 S, Bolcato V, Redaelli V, Caroppo P, Montalbetti L, Giaccone G, Osculati A. Neuropathological Alzheimer\u2019s Disease Lesions in Nasu-Hakola Disease with TREM2 Mutation: Atypical Distribution of Neurofibrillary Changes. J Alzheimers Dis. 2021;79:25\u201330.","journal-title":"J Alzheimers Dis"},{"key":"3083_CR193","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10048-015-0451-3","volume":"16","author":"A Sasaki","year":"2015","unstructured":"Sasaki A, Kakita A, Yoshida K, Konno T, Ikeuchi T, Hayashi S, Matsuo H, Shioda K. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease. Neurogenetics. 2015;16:265\u201376.","journal-title":"Neurogenetics"},{"key":"3083_CR194","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1212\/WNL.0000000000004747","volume":"89","author":"L Ghezzi","year":"2017","unstructured":"Ghezzi L, Carandini T, Arighi A, Fenoglio C, Arcaro M, De Riz M, Pietroboni AM, Fumagalli GG, Basilico P, Calvi A, et al. Evidence of CNS \u03b2-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation. Neurology. 2017;89:2503\u20135.","journal-title":"Neurology"},{"key":"3083_CR195","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1468-1331.2010.03311.x","volume":"18","author":"Y Numasawa","year":"2011","unstructured":"Numasawa Y, Yamaura C, Ishihara S, Shintani S, Yamazaki M, Tabunoki H, Satoh JI. Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family. Eur J Neurol. 2011;18:1179\u201383.","journal-title":"Eur J Neurol"},{"key":"3083_CR196","doi-asserted-by":"crossref","unstructured":"Dardiotis E, Siokas V, Pantazi E, Dardioti M, Rikos D, Xiromerisiou G, Markou A, Papadimitriou D, Speletas M, Hadjigeorgiou GM. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature. Neurobiol Aging. 2017;53:e194113\u201322.","DOI":"10.1016\/j.neurobiolaging.2017.01.015"},{"key":"3083_CR197","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1038\/s41598-020-60561-x","volume":"10","author":"R Dash","year":"2020","unstructured":"Dash R, Choi HJ, Moon IS. Mechanistic insights into the deleterious roles of Nasu-Hakola disease associated TREM2 variants. Sci Rep. 2020;10:3663.","journal-title":"Sci Rep"},{"key":"3083_CR198","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41582-025-01159-7","volume":"22","author":"J Donaldson","year":"2026","unstructured":"Donaldson J, Hensman Moss D, Ciosi M, Usdin K, Balmus G, Monckton DG, Tabrizi SJ. Huntington disease: somatic expansion, pathobiology and therapeutics. Nat Rev Neurol. 2026;22:5\u201321.","journal-title":"Nat Rev Neurol"},{"key":"3083_CR199","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/mds.27911","volume":"35","author":"R Vuono","year":"2020","unstructured":"Vuono R, Kouli A, Legault EM, Chagnon L, Allinson KS, La Spada A, Biunno I, Barker RA, Drouin-Ouellet J. Association Between Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington\u2019s Disease. Mov Disord. 2020;35:401\u20138.","journal-title":"Mov Disord"},{"key":"3083_CR200","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1038\/s41598-018-21788-x","volume":"8","author":"LM Byrne","year":"2018","unstructured":"Byrne LM, Rodrigues FB, Johnson EB, De Vita E, Blennow K, Scahill R, Zetterberg H, Heslegrave A, Wild EJ. Cerebrospinal fluid neurogranin and TREM2 in Huntington\u2019s disease. Sci Rep. 2018;8:4260.","journal-title":"Sci Rep"},{"key":"3083_CR201","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-180018","volume":"63","author":"V Redaelli","year":"2018","unstructured":"Redaelli V, Salsano E, Colleoni L, Corbetta P, Tringali G, Del Sole A, Giaccone G, Rossi G. Frontotemporal Dementia and Chorea Associated with a Compound Heterozygous TREM2 Mutation. J Alzheimers Dis. 2018;63:195\u2013201.","journal-title":"J Alzheimers Dis"},{"key":"3083_CR202","doi-asserted-by":"publisher","first-page":"e24192423","DOI":"10.1016\/j.neurobiolaging.2014.04.010","volume":"35","author":"I Le Ber","year":"2014","unstructured":"Le Ber I, De Septenville A, Guerreiro R, Bras J, Camuzat A, Caroppo P, Lattante S, Couarch P, Kabashi E, Bouya-Ahmed K, et al. Homozygous TREM2 mutation in a family with atypical frontotemporal dementia. Neurobiol Aging. 2014;35:e24192423\u20135.","journal-title":"Neurobiol Aging"},{"key":"3083_CR203","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/jmg-2022-108627","volume":"60","author":"N Ogonowski","year":"2023","unstructured":"Ogonowski N, Santamaria-Garcia H, Baez S, Lopez A, Laserna A, Garcia-Cifuentes E, Ayala-Ramirez P, Zarante I, Suarez-Obando F, Reyes P, et al. Frontotemporal dementia presentation in patients with heterozygous p.H157Y variant of TREM2. J Med Genet. 2023;60:894\u2013904.","journal-title":"J Med Genet"},{"key":"3083_CR204","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","volume":"131","author":"L Piccio","year":"2016","unstructured":"Piccio L, Deming Y, Del-\u00c1guila JL, Ghezzi L, Holtzman DM, Fagan AM, Fenoglio C, Galimberti D, Borroni B, Cruchaga C. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status. Acta Neuropathol. 2016;131:925\u201333.","journal-title":"Acta Neuropathol"},{"key":"3083_CR205","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Kleinberger G, Araque Caballero M, Brendel M, Rominger A, Alcolea D, Fortea J, Lle\u00f3 A, Blesa R, Gispert JD, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8:466\u201376.","journal-title":"EMBO Mol Med"},{"key":"3083_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Su\u00e1rez-Calvet","year":"2019","unstructured":"Su\u00e1rez-Calvet M, Morenas-Rodr\u00edguez E, Kleinberger G, Schlepckow K, Araque Caballero M, Franzmeier N, Capell A, Fellerer K, Nuscher B, Eren E, et al. Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegener. 2019;14:1.","journal-title":"Mol Neurodegener"},{"key":"3083_CR207","doi-asserted-by":"publisher","first-page":"369ra178","DOI":"10.1126\/scitranslmed.aag1767","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Araque Caballero M, Kleinberger G, Bateman RJ, Fagan AM, Morris JC, Levin J, Danek A, Ewers M, Haass C. Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury. Sci Transl Med. 2016;8:369ra178.","journal-title":"Sci Transl Med"},{"key":"3083_CR208","doi-asserted-by":"publisher","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C, Deming Y, Dichgans M, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med. 2019;11. https:\/\/doi.org\/10.1126\/scitranslmed.aav6221.","DOI":"10.1126\/scitranslmed.aav6221"},{"key":"3083_CR209","doi-asserted-by":"publisher","first-page":"e12308","DOI":"10.15252\/emmm.202012308","volume":"12","author":"M Ewers","year":"2020","unstructured":"Ewers M, Biechele G, Su\u00e1rez-Calvet M, Sacher C, Blume T, Morenas-Rodriguez E, Deming Y, Piccio L, Cruchaga C, Kleinberger G, et al. Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation. EMBO Mol Med. 2020;12:e12308.","journal-title":"EMBO Mol Med"},{"key":"3083_CR210","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-020-00407-2","volume":"15","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Su\u00e1rez-Calvet M, Frontzkowski L, Moore A, Hohman TJ, Morenas-Rodriguez E, Nuscher B, Shaw L, Trojanowski JQ, Dichgans M, et al. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration. Mol Neurodegener. 2020;15:57.","journal-title":"Mol Neurodegener"},{"key":"3083_CR211","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neurobiolaging.2018.10.022","volume":"74","author":"BS Rauchmann","year":"2019","unstructured":"Rauchmann BS, Schneider-Axmann T, Alexopoulos P, Perneczky R. CSF soluble TREM2 as a measure of immune response along the Alzheimer\u2019s disease continuum. Neurobiol Aging. 2019;74:182\u201390.","journal-title":"Neurobiol Aging"},{"key":"3083_CR212","doi-asserted-by":"publisher","first-page":"e0257372","DOI":"10.1371\/journal.pone.0257372","volume":"16","author":"M Bartl","year":"2021","unstructured":"Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B. Biomarkers of neurodegeneration and glial activation validated in Alzheimer\u2019s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson\u2019s disease. PLoS ONE. 2021;16:e0257372.","journal-title":"PLoS ONE"},{"key":"3083_CR213","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1177\/1352458515624558","volume":"22","author":"A \u00d6hrfelt","year":"2016","unstructured":"\u00d6hrfelt A, Axelsson M, Malmestr\u00f6m C, Novakova L, Heslegrave A, Blennow K, Lycke J, Zetterberg H. Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone. Mult Scler. 2016;22:1587\u201395.","journal-title":"Mult Scler"},{"key":"3083_CR214","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12974-022-02443-9","volume":"19","author":"MH Dong","year":"2022","unstructured":"Dong MH, Zhou LQ, Tang Y, Chen M, Xiao J, Shang K, Deng G, Qin C, Tian DS. CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study. J Neuroinflammation. 2022;19:79.","journal-title":"J Neuroinflammation"},{"key":"3083_CR215","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13195-018-0405-8","volume":"10","author":"IOC Woollacott","year":"2018","unstructured":"Woollacott IOC, Nicholas JM, Heslegrave A, Heller C, Foiani MS, Dick KM, Russell LL, Paterson RW, Keshavan A, Fox NC, et al. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup. Alzheimers Res Ther. 2018;10:79.","journal-title":"Alzheimers Res Ther"},{"key":"3083_CR216","doi-asserted-by":"crossref","first-page":"158.e151","DOI":"10.1016\/j.neurobiolaging.2021.02.024","volume":"103","author":"EL van der Ende","year":"2021","unstructured":"van der Ende EL, Morenas-Rodriguez E, McMillan C, Grossman M, Irwin D, Sanchez-Valle R, Graff C, Vandenberghe R, Pijnenburg YAL, Laforce R et al. CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia. Neurobiol Aging. 2021;103:158.e151-158.e155.","journal-title":"Neurobiol Aging"},{"key":"3083_CR217","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jneuroim.2018.08.009","volume":"324","author":"P Roos","year":"2018","unstructured":"Roos P, von Essen MR, Nielsen TT, Johannsen P, Stokholm J, Bie AS, Waldemar G, Simonsen AH, Heslegrave A, Zetterberg H, et al. Inflammatory markers of CHMP2B-mediated frontotemporal dementia. J Neuroimmunol. 2018;324:136\u201342.","journal-title":"J Neuroimmunol"},{"key":"3083_CR218","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1177\/0271678X18817282","volume":"39","author":"K Kurisu","year":"2019","unstructured":"Kurisu K, Zheng Z, Kim JY, Shi J, Kanoke A, Liu J, Hsieh CL, Yenari MA. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke. J Cereb Blood Flow Metab. 2019;39:1906\u201318.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3083_CR219","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1523\/JNEUROSCI.2620-14.2015","volume":"35","author":"M Kawabori","year":"2015","unstructured":"Kawabori M, Kacimi R, Kauppinen T, Calosing C, Kim JY, Hsieh CL, Nakamura MC, Yenari MA. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J Neurosci. 2015;35:3384\u201396.","journal-title":"J Neurosci"},{"key":"3083_CR220","doi-asserted-by":"publisher","first-page":"e2305614","DOI":"10.1002\/advs.202305614","volume":"11","author":"S Yang","year":"2024","unstructured":"Yang S, Qin C, Chen M, Chu YH, Tang Y, Zhou LQ, Zhang H, Dong MH, Pang XW, Chen L, et al. TREM2-IGF1 Mediated Glucometabolic Enhancement Underlies Microglial Neuroprotective Properties During Ischemic Stroke. Adv Sci (Weinh). 2024;11:e2305614.","journal-title":"Adv Sci (Weinh)"},{"key":"3083_CR221","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-020-01853-x","volume":"17","author":"S Chen","year":"2020","unstructured":"Chen S, Peng J, Sherchan P, Ma Y, Xiang S, Yan F, Zhao H, Jiang Y, Wang N, Zhang JH, Zhang H. TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K\/Akt pathway after intracerebral hemorrhage in mice. J Neuroinflammation. 2020;17:168.","journal-title":"J Neuroinflammation"},{"key":"3083_CR222","doi-asserted-by":"publisher","first-page":"1520710","DOI":"10.3389\/fnins.2024.1520710","volume":"18","author":"Y Yao","year":"2024","unstructured":"Yao Y, Hu L, Li D, Wang Y, Pan J, Fan D. Perioperative enriched environment attenuates postoperative cognitive dysfunction by upregulating microglia TREM2 via PI3K\/Akt pathway in mouse model of ischemic stroke. Front Neurosci. 2024;18:1520710.","journal-title":"Front Neurosci"},{"key":"3083_CR223","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1161\/STROKEAHA.124.049745","volume":"56","author":"JB Yu","year":"2025","unstructured":"Yu JB, Hong C, Ren XW, Guo W, Chen YF, Ji J, Zhang XY, Sun XL. FTY720 Modulating Microglia-Mediated Cholesterol Recycling via TREM2 Promotes Remyelination Following Ischemic Damage. Stroke. 2025;56:1897\u2013908.","journal-title":"Stroke"},{"key":"3083_CR224","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.apsb.2021.10.012","volume":"12","author":"T Xue","year":"2022","unstructured":"Xue T, Ji J, Sun Y, Huang X, Cai Z, Yang J, Guo W, Guo R, Cheng H, Sun X. Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury. Acta Pharm Sin B. 2022;12:1885\u201398.","journal-title":"Acta Pharm Sin B"},{"key":"3083_CR225","doi-asserted-by":"publisher","first-page":"111156","DOI":"10.1016\/j.brainresbull.2024.111156","volume":"220","author":"X Zhang","year":"2025","unstructured":"Zhang X, Du P, Bai B, Lian X, Xue G. Molecular mechanism of METTL14-mediated m6A modification regulating microglial function post ischemic stroke. Brain Res Bull. 2025;220:111156.","journal-title":"Brain Res Bull"},{"key":"3083_CR226","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/glia.24597","volume":"72","author":"C Wang","year":"2024","unstructured":"Wang C, Dong J, Huang H, Zhou K, Liu Z, Milner R, Li L. Astrocyte-TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke. Glia. 2024;72:2061\u201378.","journal-title":"Glia"},{"key":"3083_CR227","doi-asserted-by":"publisher","unstructured":"Salafia G, Carandina A, Sacco RM, Ferri E, Montano N, Arosio B, Tobaldini E. Soluble Triggering Receptors Expressed on Myeloid Cells (sTREM) in Acute Ischemic Stroke: A Potential Pathway of sTREM-1 and sTREM-2 Associated with Disease Severity. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25147611.","DOI":"10.3390\/ijms25147611"},{"key":"3083_CR228","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12974-022-02440-y","volume":"19","author":"Y Lu","year":"2022","unstructured":"Lu Y, Zhao Y, Zhang Q, Fang C, Bao A, Dong W, Peng Y, Peng H, Ju Z, He J, et al. Soluble TREM2 is associated with death and cardiovascular events after acute ischemic stroke: an observational study from CATIS. J Neuroinflammation. 2022;19:88.","journal-title":"J Neuroinflammation"},{"key":"3083_CR229","doi-asserted-by":"publisher","first-page":"112629","DOI":"10.1016\/j.celrep.2023.112629","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao H, Di J, Clausen BH, Wang N, Zhu X, Zhao T, Chang Y, Pang M, Yang Y, He R, et al. Distinct myeloid population phenotypes dependent on TREM2 expression levels shape the pathology of traumatic versus demyelinating CNS disorders. Cell Rep. 2023;42:112629.","journal-title":"Cell Rep"},{"key":"3083_CR230","first-page":"65","volume":"25","author":"S Liu","year":"2021","unstructured":"Liu S, Li XM, Yuan JB, Li LL, Wang C, Lin XM, Miao X, Shi ZC. MiR-665 inhibits inflammatory response in microglia following spinal cord injury by targeting TREM2. Eur Rev Med Pharmacol Sci. 2021;25:65\u201370.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3083_CR231","doi-asserted-by":"publisher","unstructured":"Zhao T, Di J, Kang Y, Zhang H, Yao S, Liu B, Rong L. TREM2 Impedes Recovery After Spinal Cord Injury by Regulating microglial lysosomal membrane permeabilization-mediated autophagy. Cell Prolif. 2025:e70047. https:\/\/doi.org\/10.1111\/cpr.70047.","DOI":"10.1111\/cpr.70047"},{"key":"3083_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2017.05.006","volume":"105","author":"EL Castranio","year":"2017","unstructured":"Castranio EL, Mounier A, Wolfe CM, Nam KN, Fitz NF, Letronne F, Schug J, Koldamova R, Lefterov I. Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury. Neurobiol Dis. 2017;105:1\u201314.","journal-title":"Neurobiol Dis"},{"key":"3083_CR233","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12974-022-02651-3","volume":"19","author":"J Yan","year":"2022","unstructured":"Yan J, Zhang Y, Wang L, Li Z, Tang S, Wang Y, Gu N, Sun X, Li L. TREM2 activation alleviates neural damage via Akt\/CREB\/BDNF signalling after traumatic brain injury in mice. J Neuroinflammation. 2022;19:289.","journal-title":"J Neuroinflammation"},{"key":"3083_CR234","doi-asserted-by":"publisher","first-page":"e1665","DOI":"10.1002\/ctm2.1665","volume":"14","author":"Z Li","year":"2024","unstructured":"Li Z, Yu S, Li L, Zhou C, Wang L, Tang S, Gu N, Zhang Z, Huang Z, Chen H, et al. TREM2 alleviates white matter injury after traumatic brain injury in mice might be mediated by regulation of DHCR24\/LXR pathway in microglia. Clin Transl Med. 2024;14:e1665.","journal-title":"Clin Transl Med"},{"key":"3083_CR235","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/neu.2016.4401","volume":"34","author":"M Saber","year":"2017","unstructured":"Saber M, Kokiko-Cochran O, Puntambekar SS, Lathia JD, Lamb BT. Triggering Receptor Expressed on Myeloid Cells 2 Deficiency Alters Acute Macrophage Distribution and Improves Recovery after Traumatic Brain Injury. J Neurotrauma. 2017;34:423\u201335.","journal-title":"J Neurotrauma"},{"key":"3083_CR236","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, Wilcock DM. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflammation. 2020;17:238.","journal-title":"J Neuroinflammation"},{"key":"3083_CR237","doi-asserted-by":"publisher","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O, Paul R, Gilfillan S, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020;217. https:\/\/doi.org\/10.1084\/jem.20200785.","DOI":"10.1084\/jem.20200785"},{"key":"3083_CR238","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","volume":"16","author":"H Long","year":"2024","unstructured":"Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H, Tassi I, Ward M, et al. Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease. Alzheimers Res Ther. 2024;16:235.","journal-title":"Alzheimers Res Ther"},{"key":"3083_CR239","doi-asserted-by":"publisher","unstructured":"Mummery CJ, Mayorga AJ, Simmons A, Chow TW, Burgess B, Nguyen T, Gao J, Budda B, Park LQ, Gupta R, et al. The TREM2 agonistic antibody AL002 in early Alzheimer\u2019s disease: a phase 2 randomized trial. Nat Med. 2026. https:\/\/doi.org\/10.1038\/s41591-026-04273-1.","DOI":"10.1038\/s41591-026-04273-1"},{"key":"3083_CR240","doi-asserted-by":"publisher","first-page":"e11227","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, Willem M, Werner G, Pettkus N, Brunner B, et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020;12:e11227.","journal-title":"EMBO Mol Med"},{"key":"3083_CR241","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12974-020-01980-5","volume":"18","author":"M Fassler","year":"2021","unstructured":"Fassler M, Rappaport MS, Cu\u00f1o CB, George J. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer\u2019s disease models. J Neuroinflammation. 2021;18:19.","journal-title":"J Neuroinflammation"},{"key":"3083_CR242","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41593-022-01240-0","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, Tatarakis D, Calvert M, Hummel S, Lianoglou S, et al. A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci. 2023;26:416\u201329.","journal-title":"Nat Neurosci"},{"key":"3083_CR243","doi-asserted-by":"publisher","first-page":"eabq0095","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang L, Fan X, Li L, Li X, Arase H, Zhao Y, Cao W, Zheng H, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14:eabq0095.","journal-title":"Sci Transl Med"},{"key":"3083_CR244","doi-asserted-by":"publisher","first-page":"2107971","DOI":"10.1080\/19420862.2022.2107971","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Fan X, Li L, Li X, Arase H, Tong Q, Zhang N, An Z. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice. MAbs. 2022;14:2107971. https:\/\/doi.org\/10.1080\/19420862.2022.2107971.","journal-title":"MAbs"},{"key":"3083_CR245","doi-asserted-by":"publisher","unstructured":"Ellwanger DC, Wang S, Brioschi S, Shao Z, Green L, Case R, Yoo D, Weishuhn D, Rathanaswami P, Bradley J, et al. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2021;118. https:\/\/doi.org\/10.1073\/pnas.2017742118.","DOI":"10.1073\/pnas.2017742118"},{"key":"3083_CR246","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.1038\/s41598-021-92906-5","volume":"11","author":"P Li","year":"2021","unstructured":"Li P, Shen T, Luo X, Yang J, Luo Z, Tan Y, He G, Wang Z, Yu X, Wang Y, Yang X. Modulation of microglial phenotypes by dexmedetomidine through TREM2 reduces neuroinflammation in heatstroke. Sci Rep. 2021;11:13345.","journal-title":"Sci Rep"},{"key":"3083_CR247","doi-asserted-by":"publisher","first-page":"110006","DOI":"10.1016\/j.neuropharm.2024.110006","volume":"255","author":"J Wang","year":"2024","unstructured":"Wang J, Du L, Zhang T, Chu Y, Wang Y, Wang Y, Ji X, Kang Y, Cui R, Zhang G, et al. Edaravone Dexborneol ameliorates the cognitive deficits of APP\/PS1 mice by inhibiting TLR4\/MAPK signaling pathway via upregulating TREM2. Neuropharmacology. 2024;255:110006.","journal-title":"Neuropharmacology"},{"key":"3083_CR248","doi-asserted-by":"crossref","unstructured":"Moretti M, Caraffi R, Lorenzini L, Ottonelli I, Sannia M, Alastra G, Baldassarro VA, Giuliani A, Duskey JT, Cescatti M et al. Combo multi-target pharmacological therapy and new formulations to reduce inflammation and improve endogenous remyelination in traumatic spinal cord injury. Cells. 2023;12.","DOI":"10.3390\/cells12091331"},{"key":"3083_CR249","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/cns.13444","volume":"26","author":"L Belayev","year":"2020","unstructured":"Belayev L, Hong SH, Freitas RS, Menghani H, Marcell SJ, Khoutorova L, Mukherjee PK, Reid MM, Oria RB, Bazan NG. DHA modulates MANF and TREM2 abundance, enhances neurogenesis, reduces infarct size, and improves neurological function after experimental ischemic stroke. CNS Neurosci Ther. 2020;26:1155\u201367.","journal-title":"CNS Neurosci Ther"},{"key":"3083_CR250","doi-asserted-by":"publisher","unstructured":"Wang M, Zhao R, Su Y, Zhai D, Liang H, Zhang L, Wang W, Wang Z, Qi M, Jiang X, et al. 4,4\u2019-Dimethoxychalcone Mitigates Neuroinflammation Following Traumatic Brain Injury Through Modulation of the TREM2\/PI3K\/AKT\/NF-\u03baB Signaling Pathway. Inflammation. 2025. https:\/\/doi.org\/10.1007\/s10753-025-02279-4.","DOI":"10.1007\/s10753-025-02279-4"},{"key":"3083_CR251","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1007\/s12035-023-03875-x","volume":"61","author":"C Zhang","year":"2024","unstructured":"Zhang C, Xu C, Jing Y, Cao H, Wang X, Zhao J, Gong Q, Chen S. Deferoxamine Induces Autophagy Following Traumatic Brain Injury via TREM2 on Microglia. Mol Neurobiol. 2024;61:4649\u201362.","journal-title":"Mol Neurobiol"},{"key":"3083_CR252","doi-asserted-by":"publisher","first-page":"132179","DOI":"10.1016\/j.ijbiomac.2024.132179","volume":"269","author":"R Yang","year":"2024","unstructured":"Yang R, Li DD, Li XX, Yang XX, Gao HM, Zhang F. Dihydroquercetin alleviates dopamine neuron loss via regulating TREM2 activation. Int J Biol Macromol. 2024;269:132179.","journal-title":"Int J Biol Macromol"},{"key":"3083_CR253","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s11064-021-03484-x","volume":"47","author":"M Ren","year":"2022","unstructured":"Ren M, Zhang M, Zhang X, Wang C, Zheng Y, Hu Y. Hydroxysafflor Yellow A Inhibits A\u03b2(1\u201342)-Induced Neuroinflammation by Modulating the Phenotypic Transformation of Microglia via TREM2\/TLR4\/NF-\u03baB Pathway in BV-2 Cells. Neurochem Res. 2022;47:748\u201361. https:\/\/doi.org\/10.1007\/s11064-021-03484-x.","journal-title":"Neurochem Res"},{"key":"3083_CR254","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11064-025-04375-1","volume":"50","author":"F Cao","year":"2025","unstructured":"Cao F, Zhang P, Chi Y, Wang Y, Xu L, Zhang D. Celastrol Ameliorated Alzheimer\u2019s Disease in Mice by Enhancing TBX21\/TREM2 Expression in Microglia and Inhibiting Tau Phosphorylation. Neurochem Res. 2025;50:126.","journal-title":"Neurochem Res"},{"key":"3083_CR255","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1007\/s12035-022-02873-9","volume":"59","author":"JH Sanjay, Shin","year":"2022","unstructured":"Sanjay, Shin JH, Park M, Lee HJ. Cyanidin-3-O-Glucoside Regulates the M1\/M2 Polarization of Microglia via PPAR\u03b3 and A\u03b242 Phagocytosis Through TREM2 in an Alzheimer\u2019s Disease Model. Mol Neurobiol. 2022;59:5135\u201348. https:\/\/doi.org\/10.1007\/s12035-022-02873-9.","journal-title":"Mol Neurobiol"},{"key":"3083_CR256","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13020-025-01098-x","volume":"20","author":"RK Pang","year":"2025","unstructured":"Pang RK, Shi J, Peng XY, Su S, Zheng JY, Le K, Keng VW, Zhang SJ, Li XX. Huang-Lian-Jie-Du decoction alleviates cognitive deficits in Alzheimer\u2019s disease model 5xFAD mice by inhibiting Trem2\/Dap12 signaling pathway. Chin Med. 2025;20:50.","journal-title":"Chin Med"},{"key":"3083_CR257","doi-asserted-by":"publisher","first-page":"8024","DOI":"10.1038\/s41467-024-52301-w","volume":"15","author":"R Milazzo","year":"2024","unstructured":"Milazzo R, Montepeloso A, Kumar R, Ferro F, Cavalca E, Rigoni P, Cabras P, Ciervo Y, Das S, Capotondo A, et al. Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer\u2019s disease mouse model. Nat Commun. 2024;15:8024.","journal-title":"Nat Commun"},{"key":"3083_CR258","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","volume":"18","author":"S Jiang","year":"2024","unstructured":"Jiang S, Cai G, Yang Z, Shi H, Zeng H, Ye Q, Hu Z, Wang Z. Biomimetic Nanovesicles as a Dual Gene Delivery System for the Synergistic Gene Therapy of Alzheimer\u2019s Disease. ACS Nano. 2024;18:11753\u201368.","journal-title":"ACS Nano"},{"key":"3083_CR259","doi-asserted-by":"publisher","first-page":"121360","DOI":"10.1016\/j.biomaterials.2021.121360","volume":"281","author":"P Wang","year":"2022","unstructured":"Wang P, Yang P, Qian K, Li Y, Xu S, Meng R, Guo Q, Cheng Y, Cao J, Xu M, et al. Precise gene delivery systems with detachable albumin shell remodeling dysfunctional microglia by TREM2 for treatment of Alzheimer\u2019s disease. Biomaterials. 2022;281:121360.","journal-title":"Biomaterials"},{"key":"3083_CR260","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12974-023-02741-w","volume":"20","author":"J Xu","year":"2023","unstructured":"Xu J, Zhang L, Li M, He X, Luo J, Wu R, Hong Z, Zheng H, Hu X. TREM2 mediates physical exercise-promoted neural functional recovery in rats with ischemic stroke via microglia-promoted white matter repair. J Neuroinflammation. 2023;20:50.","journal-title":"J Neuroinflammation"},{"key":"3083_CR261","doi-asserted-by":"publisher","first-page":"119526","DOI":"10.1016\/j.lfs.2021.119526","volume":"278","author":"T Jiang","year":"2021","unstructured":"Jiang T, Luo J, Pan X, Zheng H, Yang H, Zhang L, Hu X. Physical exercise modulates the astrocytes polarization, promotes myelin debris clearance and remyelination in chronic cerebral hypoperfusion rats. Life Sci. 2021;278:119526.","journal-title":"Life Sci"},{"key":"3083_CR262","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-022-02401-5","volume":"19","author":"SS Zhang","year":"2022","unstructured":"Zhang SS, Zhu L, Peng Y, Zhang L, Chao FL, Jiang L, Xiao Q, Liang X, Tang J, Yang H, et al. Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP\/PS1 mice. J Neuroinflammation. 2022;19:34.","journal-title":"J Neuroinflammation"},{"key":"3083_CR263","doi-asserted-by":"publisher","first-page":"111280","DOI":"10.1016\/j.brainresbull.2025.111280","volume":"223","author":"L Zhang","year":"2025","unstructured":"Zhang L, Liu Y, Wang X, Wu H, Xie J, Liu Y. Treadmill exercise ameliorates hippocampal synaptic injury and recognition memory deficits by TREM2 in AD rat model. Brain Res Bull. 2025;223:111280.","journal-title":"Brain Res Bull"},{"key":"3083_CR264","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13195-024-01489-6","volume":"16","author":"X Wang","year":"2024","unstructured":"Wang X, Xie Y, Fan X, Wu X, Wang D, Zhu L. Intermittent hypoxia training enhances A\u03b2 endocytosis by plaque associated microglia via VPS35-dependent TREM2 recycling in murine Alzheimer\u2019s disease. Alzheimers Res Ther. 2024;16:121.","journal-title":"Alzheimers Res Ther"},{"key":"3083_CR265","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12974-021-02144-9","volume":"18","author":"M Hu","year":"2021","unstructured":"Hu M, Lin Y, Men X, Wang S, Sun X, Zhu Q, Lu D, Liu S, Zhang B, Cai W, Lu Z. High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke. J Neuroinflammation. 2021;18:90.","journal-title":"J Neuroinflammation"},{"key":"3083_CR266","doi-asserted-by":"crossref","unstructured":"Etxeberria A, Shen YA, Vito S, Silverman SM, Imperio J, Lalehzadeh G, Soung AL, Du C, Xie L, Choy MK et al. Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer\u2019s Disease and Multiple Sclerosis. J Neurosci. 2024;44.","DOI":"10.1523\/JNEUROSCI.2347-23.2024"},{"key":"3083_CR267","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.stem.2023.07.006","volume":"30","author":"Y Yoo","year":"2023","unstructured":"Yoo Y, Neumayer G, Shibuya Y, Mader MM, Wernig M. A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer\u2019s disease. Cell Stem Cell. 2023;30:1043\u2013e10531046.","journal-title":"Cell Stem Cell"},{"key":"3083_CR268","doi-asserted-by":"publisher","first-page":"e35800","DOI":"10.1016\/j.heliyon.2024.e35800","volume":"10","author":"K Wang","year":"2024","unstructured":"Wang K, Zan S, Xu J, Sun W, Li C, Zhang W, Ni D, Cheng R, Li L, Yu Z, et al. Yishen Huazhuo decoction regulates microglial polarization to reduce Alzheimer\u2019s disease-related neuroinflammation through TREM2. Heliyon. 2024;10:e35800.","journal-title":"Heliyon"},{"key":"3083_CR269","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2337\/db13-1869","volume":"64","author":"M Park","year":"2015","unstructured":"Park M, Yi JW, Kim EM, Yoon IJ, Lee EH, Lee HY, Ji KY, Lee KH, Jang JH, Oh SS, et al. Triggering receptor expressed on myeloid cells 2 (TREM2) promotes adipogenesis and diet-induced obesity. Diabetes. 2015;64:117\u201327.","journal-title":"Diabetes"},{"key":"3083_CR270","doi-asserted-by":"publisher","first-page":"111438","DOI":"10.1016\/j.mad.2021.111438","volume":"195","author":"Q Qin","year":"2021","unstructured":"Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Y. TREM2, microglia, and Alzheimer\u2019s disease. Mech Ageing Dev. 2021;195:111438.","journal-title":"Mech Ageing Dev"},{"key":"3083_CR271","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12035-022-03094-w","volume":"60","author":"C Zhang","year":"2023","unstructured":"Zhang C, Chen S. Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury. Mol Neurobiol. 2023;60:342\u201354.","journal-title":"Mol Neurobiol"},{"key":"3083_CR272","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fncel.2018.00206","volume":"12","author":"H Konishi","year":"2018","unstructured":"Konishi H, Kiyama H. Microglial TREM2\/DAP12 Signaling: A Double-Edged Sword in Neural Diseases. Front Cell Neurosci. 2018;12:206.","journal-title":"Front Cell Neurosci"},{"key":"3083_CR273","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1074\/jbc.R115.704981","volume":"291","author":"J Walter","year":"2016","unstructured":"Walter J. The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases. J Biol Chem. 2016;291:4334\u201341.","journal-title":"J Biol Chem"},{"key":"3083_CR274","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.immuni.2025.04.022","volume":"58","author":"R Morini","year":"2025","unstructured":"Morini R, Tagliatti E, Bizzotto M, Matteoli M. Microglial and TREM2 dialogues in the developing brain. Immunity. 2025;58:1068\u201384.","journal-title":"Immunity"},{"key":"3083_CR275","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/10738584211040786","volume":"29","author":"W Qu","year":"2023","unstructured":"Qu W, Li L. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer\u2019s Disease. Neuroscientist. 2023;29:302\u201316.","journal-title":"Neuroscientist"},{"key":"3083_CR276","doi-asserted-by":"publisher","first-page":"795036","DOI":"10.3389\/fimmu.2021.795036","volume":"12","author":"XX Li","year":"2021","unstructured":"Li XX, Zhang F. Targeting TREM2 for Parkinson\u2019s Disease: Where to Go? Front Immunol. 2021;12:795036.","journal-title":"Front Immunol"},{"key":"3083_CR277","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41582-020-0404-9","volume":"16","author":"H Wood","year":"2020","unstructured":"Wood H. TREM2 activation promotes remyelination. Nat Rev Neurol. 2020;16:522.","journal-title":"Nat Rev Neurol"},{"key":"3083_CR278","doi-asserted-by":"publisher","first-page":"978423","DOI":"10.3389\/fimmu.2022.978423","volume":"13","author":"A Katsumoto","year":"2022","unstructured":"Katsumoto A, Kokiko-Cochran ON, Bemiller SM, Xu G, Ransohoff RM, Lamb BT. Triggering receptor expressed on myeloid cells 2 deficiency exacerbates injury-induced inflammation in a mouse model of tauopathy. Front Immunol. 2022;13:978423.","journal-title":"Front Immunol"},{"key":"3083_CR279","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13024-025-00867-4","volume":"20","author":"MY Noh","year":"2025","unstructured":"Noh MY, Kwon HS, Kwon MS, Nahm M, Jin HK, Bae JS, Kim SH. Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions. Mol Neurodegener. 2025;20:82.","journal-title":"Mol Neurodegener"},{"key":"3083_CR280","doi-asserted-by":"publisher","first-page":"102471","DOI":"10.1016\/j.arr.2024.102471","volume":"101","author":"X Fan","year":"2024","unstructured":"Fan X, Chen H, He W, Zhang J. Emerging microglial biology highlights potential therapeutic targets for Alzheimer\u2019s disease. Ageing Res Rev. 2024;101:102471.","journal-title":"Ageing Res Rev"},{"key":"3083_CR281","doi-asserted-by":"publisher","unstructured":"Roveta F, Bonino L, Piella EM, Rainero I, Rubino E. Neuroinflammatory Biomarkers in Alzheimer\u2019s Disease: From Pathophysiology to Clinical Implications. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms252211941.","DOI":"10.3390\/ijms252211941"},{"key":"3083_CR282","doi-asserted-by":"publisher","first-page":"114371","DOI":"10.1016\/j.expneurol.2023.114371","volume":"363","author":"YY Wang","year":"2023","unstructured":"Wang YY, Zhou YN, Jiang L, Wang S, Zhu L, Zhang SS, Yang H, He Q, Liu L, Xie YH, et al. Long-term voluntary exercise inhibited AGE\/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP\/PS1 transgenic mice. Exp Neurol. 2023;363:114371.","journal-title":"Exp Neurol"},{"key":"3083_CR283","doi-asserted-by":"publisher","first-page":"113820","DOI":"10.1016\/j.physbeh.2022.113820","volume":"251","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu Y, Wang X, Wang D, Wu H, Chen H, Chen J, Liu Y. Treadmill exercise improve recognition memory by TREM2 pathway to inhibit hippocampal microglial activation and neuroinflammation in Alzheimer\u2019s disease model. Physiol Behav. 2022;251:113820.","journal-title":"Physiol Behav"},{"key":"3083_CR284","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.gendis.2020.05.005","volume":"9","author":"M Wu","year":"2022","unstructured":"Wu M, Liao M, Huang R, Chen C, Tian T, Wang H, Li J, Li J, Sun Y, Wu C, et al. Hippocampal overexpression of TREM2 ameliorates high fat diet induced cognitive impairment and modulates phenotypic polarization of the microglia. Genes Dis. 2022;9:401\u201314.","journal-title":"Genes Dis"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03083-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03083-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03083-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:03:13Z","timestamp":1791507793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03083-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":284,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3083"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03083-9","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"16 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"542"}}